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I. INTRODUCTION
Forensic science has recently proclaimed a revolution in its abil-
ity to differentiate one person's blood from that of another.1 Scien-
tists who study blood groupings believe that each person's blood is
unique: that a person's blood is as individual as that person's
fingerprints.2 Although scientists concede that such individualiza-
tion of blood is not now possible, many feel that it will be only a
* Associate Professor of Law, Pace University Law School; A.B., Princeton University,
1967; J.D., University of Chicago Law School, 1970; LL.M., New York University Law
School, 1971. The author gratefully acknowledges the editorial assistance of Dr. G. Miller
Jonakait and the research assistance of Linda R. Tacoma.
I "In criminal matters, the evidential value associated with bloodstains remained very
limited until about ten to fifteen years ago. Since then forensic blood grouping has gone
through a period of revolution. . . . "Baird, The Individuality of Blood and Bloodstains,
11 J. CAN. Soc'Y FoRENsIc ScL 83, 121 (1978).
" See, e.g., Grunbaum, Potential and Limitations of Forensic Blood Analysis, in HAND-
BOOK FOR FORENSIC INDIVIDUALIZATION OF HUMAN BLOOD AND BLOODSTAINS 1, 2 (B.
Grunbaum ed. 1981). Grunbaum states that "A simile has been drawn between fingerprints
and blood as forensic evidence because both are unique to the individual and both are un-
changing throughout life." See also Diamond, The Story of our Blood Groups, in BLOOD,
PURE AND ELOQUENT 691 (M. Wintrobe ed. 1980). Diamond states that:
From this modest start of four types, the individual characteristics of blood cells
have been so greatly expanded that it is now highly improbable that any two peo-
ple except identical twins would have the same combination of red cell surface
markers. In other words, every person on earth is unique in his or her combination
of blood groups-a fact recognized only in the past thirty years.
Id. As this indicates, blood grouping evidence will never have precisely the same value as
fingerprints, for although identical twins do have the same blood groupings, see Terasaki,
Resolution by HLA Testing of 1000 Paternity Cases Not Excluded by ABO Testing, 16 J.
FAM. L. 543, 549 (1978), even identical twins have different fingerprints, see Baxter, Group-
ing of Blood Stains: Present and Future Trends, 12 CAL. W.L. RBv. 284, 284-85 (1976).
3 A noted British forensic serologist has concluded: "It is not yet possible to individual-
ize blood in the same way as one can a fingerprint, but this is because of a lack of knowledge
of techniques and not because of the nature of blood." B. CULLFoRD, THE EXAMINATION AND
TYPING OF BLOODSTAINS IN THE CRmE LABORATORY 15 (1971). An American forensic serolo-
gist states, however, that "[a]bsolute individualization of blood, while theoretically possible,
is not a practical goal for any laboratory." Grunbaum, supra note 2, at 2. See also Baird,
supra note 1, at 88. Two other scientists have argued that the present trends in blood-
typing research will not lead to the desired end of individualizing bloodstains. They contend
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matter of time until that goal is achieved.4 Right now, they con-
tend, recent discoveries have provided significant advances in the
ability to tell one blood sample from another so that it is almost
possible to determine whether a particular specimen of blood came
from a specific person. Already, the scientific advances produce
powerful testimony in criminal trials.
The effectiveness of scientific testimony at a criminal trial is il-
lustrated by what transpires once a bloodstain is found at a mur-
der scene. The blood is typed along with the blood of the victim.
The two samples do not match. Circumstantial evidence indicates
that the blood was shed by the murderer. A suspect is arrested. A
sample of his blood is taken and typed. At the subsequent trial, a
forensic scientist testifies that the blood samples were grouped not
only by traditional typing tests, but also by newer procedures
which are able to determine many more factors in the blood than
the older methods. He states that even though the tests are of re-
cent origin, they are used by many crime laboratories and are well-
accepted in his field. The scientist further testifies that studies
have been made to determine how often each particular blood-type
occurs in the general population, and that therefore, he can calcu-
late the frequency with which a particular combination of blood
factors appear. He concludes that the bloodstain at the murder
scene matches the defendant's blood, and that only one in a thou-
sand people have blood like this. This powerful evidence helps per-
suade the jury to convict the defendant.
that current research "lacks the potential for attainment of what is probably the primary
goal of forensic serology-the 'fingerprinting' or individualization of human bloodstains.
This is so because typing detects only qualitative differences ... ." Sweet & Elvins, Stud-
ies by Crossed Electroimmunodiffusion on the Individuality and Sexual Origin of Blood-
stains, 21 J. FORENSIC SCL 498, 505 (1976). Since no one is unique in these types, they
conclude, "[c]learly, if individualization of bloodstains is to become a reality a technique
must detect not only differences in kind but also in quantity." Id.
I In 1976, a forensic scientist stated that "[t]he evolution of forensic blood grouping is
likely to reach a point in the next decade where the goal of identifying the individual is
achieved." Baxter, supra note 2, at 286.'Culliford suggests that perhaps in the future, blood-
typing of all convicted criminals will be done and kept on record just as fingerprints are
filed. B. CuLu soR, supra note 3, at 17.
1 See Baird, supra note 1, at 121. Baird states that "we are now facing a situation
wherein it is almost possible to characterize human bloodstains to the extent that they can
be as individualistic as fingerprints." Id.
[Vol. 31834
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This narrative is a composite of several real cases," and the fo-
rensic evidence is not purely hypothetical. Increasingly, the foren-
sic serologists' belief in a blood-typing revolution is reflected in
criminal litigation. More and more cases are being reported in
which expert testimony concerning the new blood-typing proce-
dures has been admitted.7 Since crime laboratories have only re-
cently started to use these tests, such testimony should increase
dramatically in the next few years, and will become nearly as com-
mon, and just as persuasive, as fingerprint testimony. A tremen-
dous new tool will be in the prosecution's hands.
The use of these new procedures has, however, received little
scrutiny and few cases show any challenge to the recently devel-
oped procedures for typing blood." Perhaps that is because blood-
typing has long been considered acceptable by our courts.' This
new revolutionary evidence, however, is not the same as previous
blood-typing evidence. The new procedures are unrelated to the
long-accepted ones and their use should be raising important is-
sues. Are these procedures reliable? Do they perform as their par-
tisans proclaim? If this new evidence is frequently wrong or mis-
leading, the prosecution may have added a powerful weapon to its
arsenal, but one that will work injustices. These questions have not
yet been addressed.
The purpose of this article is to examine these procedures in de-
tail, to decide what the proper legal test for the determination of
the blood-typing procedure's admissibility in criminal cases should
6 See infra note 8 and text accompanying notes 78-122 for a discussion of the cases
from which this narrative is drawn.
7 Beginning in 1978, there are reported cases in which defendants did not challenge the
use of new blood typing procedures. See, e.g., People v. Stephens, 81 Cal. App. 3d 744, 146
Cal. Rptr. 748 (2d Dist. 1978); State v. Hampton, 294 N.C. 242, 239 S.E.2d 835 (1978).
8 In some cases, for example, even though the new blood grouping tests were introduced
by the prosecution, the reported decision does not indicate that the defendant even chal-
lenged the evidence. See People v. Stephens, 81 Cal. App. 3d 744, 146 Cal. Rptr. 748 (2d
Dist. 1978); State v. Anderson, 308 N.W.2d 42 (Iowa 1981); State v. Hanson, 587 S.W.2d 895
(Mo. Ct. App. 1979); State v. Hampton, 294 N.C. 242, 239 S.E.2d 835 (1978). In other cases,
although the statistics generated by the blood grouping testimony were litigated, the sero-
logical tests themselves were not. See State v. Rolls, 389 A.2d 824 (Me. 1978); State v. Carl-
son, 267 N.W.2d 170 (Minn. 1978); State v. Fulton, 299 N.C. 491, 263 S.E.2d 608 (1980).
Annot., 2 A.L.R.4th 500 (1980).
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be, and to present information about the reliability of the proce-
dures. As shall be demonstrated, the new tests have not yet been
proven reliable, and therefore, should not yet be admitted into
criminal cases.
A. The ABO Groups and Agglutination
Everyone's blood is not the same. In papers published in 1900
and 1901, Vienna-born Dr. Karl Landsteiner presented the results
of his pioneering research which showed "that the [blood] sera of
some of his colleagues clumped together, or agglutinated, the red
cells of others." 10 He had in fact discovered the first three blood
groups, later called A, B, and 0.
The clumping described by Landsteiner was caused by the reac-
tion between antigens, or synonymously, agglutinogens, in the red
blood cells of one sample and the antibodies, or agglutinins, in the
serum of the other blood sample.1" The reaction between the vari-
ous elements of the blood can be explained simply. Red blood cells
contain either the A antigen (type A blood), 2 the B antigen (type
B), both A and B antigens (type AB), or neither of the antigens
(type 0). The blood serum may contain antibody anti-A, anti-B,
10 Baird, supra note 1, at 87. Baird's article presents a good discussion of the history of
blood-typing. See also Diamond, supra note 2, passim (historical development of the agglu-
tination tests).
Agglutination of blood cells is a clumping of the red and white cells that are normally
suspended throughout the fluid, or serum portion of whole blood. This clumping of blood is
a reaction to the introduction of foreign antibodies into the blood. See A. MOENSSENS & F.
INBAU, SCIENTIFIC EVIDENCE IN CRIMINAL CASES §§ 6.06, 6.07 (1978); STEDMAN'S MEDICAL DIc-
TIONARY 1276 (23d ed. 1976) (definition of "serum").
11 A group of serologists stated that the classical and most useful definitions are: "[1]
An antigen is any substance which, when introduced parenterally [that is, not through the
intestines] into an individual who himself lacks that substance, stimulates the prodtiction of
an antibody, and, when mixed with the antibody, reacts specifically with it in some observa-
ble way; [2] [a]n antibody is a substance which appears in the plasma or body fluids as a
result of stimulation by an antigen and which reacts specifically with that antigen in some
observable way." K. BOORMAN, B. DODD, & P. LINCOLN, BLOOD GROUP SEROLOGY 3 (1977)
[hereinafter cited as BLOOD GROUP]. See also Terasaki, supra note 2, at 545 (giving defini-
tions of "antigen" and "antibody" similar to those provided in BLOOD GROUP, supra).
12 In 1911, antigen A was found to consist of two major subgroups, denominated A, and
A2. See Diamond, supra note 2, at 694. However, "only rarely are the reactions between A,
and A2 so sharp and distinct that they are useful in legal situations." 2 Am. JuR. PRooF oF
FACTS, Blood Types 277 (Supp. 1981).
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both antibodies, or neither. Antigen A reacts with antibody anti-A
resulting in the agglutination of the blood. Therefore, "[i]f a per-
son has A antigen in his red blood cells he cannot have an anti-A
antibody in his serum, for this would agglutinate (clump) his own
cells." 13
Blood can be readily typed in this ABO system simply by intro-
ducing into the untyped blood serum known to contain either the
anti-A or anti-B antibody. "A blood will be agglutinated by anti-A
serum, B blood will be agglutinated by anti-B serum, AB blood will
be agglutinated by both anti-A and anti-B serum, and 0 blood will
not be agglutinated by either anti-A or anti-B serum. 1 4
Landsteiner's discoveries, however, did not end with the ABO
groups. He also was instrumental in the discovery of the M, N, and
P blood groups, and of the rhesus (Rh) factor in 1940.15 Since then,
a host of other antigen-antibody blood groups have been isolated.16
All of these factors have in common that they are detected by the
traditional, agglutination tests. Each factor "depends upon an anti-
gen-antibody reaction visualized by agglutination of whole red
blood cells. No other methodology has yet been developed to iden-
tify these blood groups in routine practice." 17
Landsteiner also discovered.that he could find the blood-type of
a dried bloodstain, and recognized that this technique could be
valuable in criminal investigations.18 Despite Landsteiner's well
documented research on the M, N, and P groups, however, modem
crime laboratories seldom test for any antigen group besides the
ABO factors.19 ABO testing, however, can only produce limited re-
,3 A. MOENSSENS & F. INBAU, supra note 10, at § 6.11.
14 Id.
15 See Baird, supra note 1, at 88.
16 See generally R. RACE & R. SANGER, BLOOD GRouPs iN MAN (6th ed. 1975).
17 Zajac, Bloodstain Phenotyping in Crime Laboratory Casework, in HANDBOOK FOR
FORENSIC INDMDUALIZATION OF HUMAN BLOOD AND BLOODSTAINS 160, 163 (B. Grunbaum ed.
1981). All of the blood groups are detected by serologic tests, therefore, "[a]ny test that
detects antigens by using antisera (antibodies) is called a serologic test." Terasaki, supra
note 2, at 545.
:6 See Baird, supra note 1, at 88; Diamond, supra note 2, at 692.
9 In the crime laboratory, bloodstain evidence is most frequently typed for the
ABO group system, and often there is no determination of the other antigens....
Analysts are deterred from making antigen determinations other than ABO for
1982]
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sults because a great many people fall into each of the ABO
groups. Consequently, ABO typing by itself has little evidentiary
value in a criminal case.20
B. Electrophoresis and Polymorphic Enzymes and Proteins
Until recently, almost all the information about the blood-types
came from antigen-antibody reactions. In 1975, an authoritative
textbook in this field stated, "The great bulk of the earlier blood
group knowledge was gathered from results of simple agglutination
tests."21 Blood, however, contains many genetically controlled sub-
stances other than the red cell antigens. All of these blood compo-
nents are controlled by chromosomes and genes. Normally, every
person has twenty-three pairs of chromosomes; half of each pair
comes from each parent. Chromosomes are made up of genes.
"Each characteristic of an individual is determined by two genes,
or alleles, located at corresponding locations on the paired chromo-
somes. The pair of genes together constitute what is known as the
several reasons .... The determinations call for complicated and lengthy proce-
dures requiring numerous manipulations. A large amount of sample is needed
compared with the ABO and enzyme systems. Sensitive, specific, reliable and in-
expensive antisera for forensic use are not always available for the other antigens.
Zajac, supra note 17, at 163. Another forensic scientist has concluded, for reasons similar to
those stated by Zajac, that "it is therefore likely that as further advances are made in the
typing of blood stains, the serological methods will play a less dominant role." Baxter, supra
note 2, at 296. But cf. B. CULLiFORD, supra note 3, at 105 (contending that in time, almost
all of the antigen system will be detectable in dried blood and that the antigen Gm system is
potentially the most useful genetic marker for forensic purposes).
10 A major problem in relying on the traditional ABO typing in the context of criminal
investigations is that because the categories by blood-type are so broad, such testing does
not sufficiently narrow the class of persons who could be suspects.
For example, a suspect in a homicide may have had a bloodstain on his shirtcuff
which investigators believed could have come from the victim. How significant
would the following findings be in associating the suspect with the victim? Sup-
pose the suspect was of Group 0 while the victim was of Group A and the blood-
stain on the suspect's cuff was of Group A. We know the stain could not have
come from the suspect but on this determination alone it could have come from
the victim. On the other hand, it is realized that about forty-two percent of our
population is of Group A. Therefore, the finding of group A blood on the cuff
cannot in itself carry much weight.
Baird, supra note 1, at 103.
21 R. RACE & R. SANGER, supra note 16, at 3.
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genotype. '22
Some genes, however, exert a stronger influence than others.
"The 'more powerful' gene is called the dominant; the 'less influen-
tial' is called the recessive. '23 When a dominant is paired with a
recessive gene, the dominant one controls the observable charac-
teristics, or phenotype. In the ABO system, the A and B genes are
dominant, while the 0 gene is recessive. Thus, if a person has the
genetic pair AO, he has the genotype AO. Since, however, the A
gene is dominant while the 0 is recessive, the A controls, and that
person's phenotype is type A blood. He therefore has the same
phenotype as the person with the genotype AA.24
In 1949, scientists discovered that a particular substance in the
blood other than an antigen could appear in genetically distinct
variations.25 Scientists have since learned that blood components
exist in genetically controlled types. Such substances are said to be
polymorphic, which means "having different molecular forms but
the same biochemical function. ' 26  Blood thus contains
phosphoglucomutase (PGM), which takes different forms. One per-
son may have PGM "1," while another has PGM "2-1." In each
person, however, PGM has the same physiologic function-to "cat-
alize a reaction in the metabolism of sugars in the body. '27 PGM,
Baird, supra note 1, at 102. See also Terasaki, supra note 2, at 545 (discussion of
basic genetic terms).
23 2 Am. JUR. PROOF OF FACTS, Blood Types 611 (1959).
24 Genetic control of the blood groups is-important in criminal cases because it assures
that a person's blood-type always stays the same, except for shortly after a transfusion. See
A. MOENSSENS & F. INBAU, supra note 10, at § 6.11 ("A person's blood group remains con-
stant throughout life notwithstanding age, disease, or medication."). For a further discussion
of the implications of a transfusion on blood-types, see infra note 57. See also Grunbaum,
supra note 2, at 3 ("Since the genetic factors are permanent and unchanging throughout
life, they are of primary importance.").
The laws of inheritance are not used in the attempt to individualize a blood sample
although they are essential in paternity resolutions. See Joint AMA-ABA Guidelines: Pre-
sent Status of Serologic Testing in Problems of Disputed Parentage, 10 FAm. L.Q. 247
(1976) [hereinafter cited as Joint AMA-ABA Guidelines].
2 See A. MOURANT, A. KoPEc, & K. DOMANIEWSKA-SoBczAK, THE DISTRmUTION OF THE
HUMAN BLOOD GROUPS AND OTHER PoLymoRPisms 25 (2d ed. 1976) [hereinafter cited as
DISTRIBUTION OF HUMAN BLOOD GROUPS].
2' Grunbaum, supra note 2, at 3.
7, Baird, supra note 1, at 109.
1982l
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while existing in different molecular forms, always serves the same
purpose, and therefore is polymorphic.
While many polymorphisms have already been discovered, it is
likely that more will still be found.2 Polymorphic enzymes and
proteins,29 however, are not typed by the traditional agglutination
tests. Instead, electrophoresis is used.30 Electrophoresis is a
physical method for the separation of biologically important
proteins through the use of electric current. Proteins are very
complex molecules which assume positive, negative, or neutral
charges, depending on the solution in which they are placed.
When these charged molecules are placed on an appropriate
medium and subjected to an electrical field, they will migrate
toward the pole of the opposite charge. Blood proteins vary in
size, shape, density, and charge; consequently they vary in
electrophoretic mobility. Therefore, after electrophoresis,
they are separated into distinct bands on the supporting
medium.$'
The joint ABA-AMA committee listed sixty-three different blood systems. See Joint
AMA-ABA Guidelines, supra note 24, at 253-56, Table 1. See also DISTRIBUTION OF HUMAN
BLOop GROUPS, supra note 25, at 26. Besides PGM, other polymorphic enzymes or proteins
commonly include adenylate kinaise (AK), adensine deaminase (ADA), esterace D (EsD),
erythrocyte acid phosphotase (EAP), and haptoglobin (Hp). See infra text accompanying
note 39 for a further discussion of these polymorphic enzymes which are used as genetic
markers.
" Even though "all immediate gene products are now known to be proteins," the
polymorphisms are usually classified as the red cell antigens or the polymorphic enzymes
and proteins. DISTmBmuoN oP HUMAN BLOOD GRoups, supra note 25, at 25. See Grunbaum,
supra note 2, at 3. Enzymes are one specific kind of protein that catalyze biochemical reac-
tions, or in other words, help to convert one substance to another. See DIsmmUTON OF
HUMAN BLOOD GROUPS, supra note 25, at 25; Baird, supra note 1, at 109. The genetic vari-
ants of an enzyme are isoenzymes or isozymes. See Dismmrr0N OF HUMAN BLOOD TYPES,
supra note 25, at 25; Baird, supra note 1, at 103. Most of the polymorphic systems detected
in forensic work are enzymes. The terms "blood group" or "blood-type" are usually limited
to the antigen systems. The term "genetic marker" refers to any polymorphism whether
detected by agglutination, electrophoresis, or some other means. See Baird, supra note 1, at
105; Grunbaum, supra note 2, at 3.
30 Some scientists are attempting to perfect even newer methods with the expectation
that these refined techniques should give greater phenotyping ability than standard electro-
phoresis. See Burdett, Isoelectric Focusing in Agarose: Phosphoglucomatase (PGM Locus
1) Typing, 26 J. FORENSlC Sci. 405 (1981). Nothing indicates that forensic laboratories are
using anything other than the agglutination and electrophoretic tests in actual casework.
1 Grunbaum, supra note 2, at 3. See also A. MOENSS.NS & F. INBAU, supra note 10, at
§ 6.11; Baird, supra note 1, at 109-12.
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Subsequent to the separation, dyes that unite with one specific
protein are applied and the intensity of the resulting stain is
measured.
C. Genetic Markers in Dried Blood
The forensic serologist faces a problem which other scientists
studying blood do not. The scientist concerned with transfusions,
genetic diseases, blood disorders, or paternity resolutions is not
concerned with dried blood. The forensic scientist, however, will
most often be confronted with blood in the form of a bloodstain
-blood that has been shed by someone and aged.3 2 Dried blood
obviously is not the same as fresh blood. The antigen-antibody
tests as described above do not work with dried blood. Rather, "di-
rect agglutination tests are not possible for the detection of anti-
gens in blood stains since the red cells have been destroyed ....
"3 Other methods, however, have been devised to find the tradi-
tional blood groups in a bloodstain. These methods also depend on
the antigen-antibody reaction.
[H]owever, the technique is somewhat more complicated and
requires more expertise. [The methods] rely on the ability of
the antigen present in the bloodstain material to absorb [i.e.,
picks up] its specific anti-serum .... [I]n the ABO system, if
the bloodstain contains A, anti-A serum will be absorbed; if
the stain contains antigen B, anti-B serum will be ab-
sorbed .... The blood group can then be determined by
eluting (liberating) the absorbed serum, if any, and testing
the same against known A, B, and 0 red blood cells ....
32 One group of forensic scientists reported that "more than 90% of serological clue
materials are found on textiles," and thus more than 90% must be dried blood. See
Denault, Takimoto, Kwan, & Pallos, Detectability of Selected Genetic Markers in Dried
Blood on Aging, 25 J. FORENSIC ScL 479, 480 (1980) [hereinafter cited as Denault Study].
33 BLOOD GRouP, supra note 11, at 405. See also B. CuLmFORD, supra note 3, at 67;
Baird, supra note 1, at 84.
3, A. MOENSSENS & F. INBAU, supra note 10, at § 6.11. More than one technique is used
to detect antigens in dried blood. The one described in the text is called absorption-elution.
"Of the several methods available for the determination of antigens in dried bloodstains,
absorption-elution is the most sensitive and the most widely employed .... [A]bsorption-
elution has proved to be markedly more sensitive than the absorption-inhibition method; it
has also been reported to be more successful than mixed agglutination for certain antigens."
Denault Study, supra note 32, at 481. See also Baird, supra note 1, at 101-02; Baxter, supra
1982]
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Although the technique for testing dried blood may be refined
further, the last major advance in the typing of antigen groups in
bloodstains came in 1960. 3 The typing of genetic markers in dried
blood through the use of electrophoresis, however, did not begin in
earnest until 1968.36 The modern electrophoretic techniques with
dried blood are almost identical to the ones used with fresh blood:
"There is no difference in methodology from fresh blood to dried
blood except in preparation of the samples and in the extra care
that must be exercised in interpretation of results when degraded
material is studied. '3 7
As will be discussed below, however, blood begins to deteriorate
the moment it leaves the body, and thus, dried blood differs from
fresh. Not all genetic markers detected in fresh blood have been
successfully found in bloodstains; "experience has shown that
there are differences in the degree of detectability and persistence
of the antigen, protein and enzyme systems." 3 Consequently, a
time lag has existed between the discovery of a genetic marker in
fresh blood with that marker's identification in dried blood. There-
fore, while the discovery of the enzyme and protein genetic mark-
ers is recent, detection of them in dried blood is even more recent.
For example, of the markers now widely typed in forensic laborato-
ries, PGM was first identified in dried blood in 1969; adenylate
kinase (AK) in 1966; adenosine deaminase (ADA) in 1971; esterase
D (esD) in 1973; and erythrocyte acid phosphatase (EAP) in
note 2, at 286.
35 The advances in the typing of antigen groups in bloodstains have come about in a
somewhat hit or miss fashion. See Baird, supra note 1, at 101 ("The classical methods of
grouping dried bloodstains have evolved over the years essentially by trial and error
.... "). The first breakthrough came about in 1932, but "it was not until 1960, when Kind
introduced the absorption-elution technique, that success was achieved with small stains.
Since 1960 many workers have modified the original method of Kind .... "Baxter, supra
note 2, at 286.
36 See Baxter, supra note 2, at 286.
37 Grunbaum, Procedures for Phenotyping of Genetically Controlled Enzyme and Pro-
tein Systems, in HANDBOOK FOR FORENSIC INDIVIDUALIZATION OF HUMAN BLOOD AND BLOOD-
STAINS 51, 103 (B. Grunbaum ed. 1981). The difference in sample preparation is that the
stain must first be extracted in distilled water. Id. at 55. See also Zajac, supra note 17, at
161.
Zajac, supra note 17, at 160.
[Vol. 31
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1976.39
Consequently, many of the procedures used to identify genetic
markers in dried blood have just been developed..Many of us who
are untrained in scientific procedures are deeply impressed by re-
cent advances in technology, and want to take advantage of scien-
tific knowledge as soon as it becomes available. The law, however,
has a duty to ask and to answer an important question before
these tests become admissible as evidence: Should these new scien-
tific tests be admitted into criminal cases?
II. THE LEGAL STANDARD FOR ADMITTING THE GENETIC MARKER
TESTS
Whether the blood tests are admissible can only be deter-
mined after first deciding what legal standard should govern their
admissibility. This section of the paper will examine the tradi-
tional norm for assessing the admissibility of new scientific evi-
dence. It will show that the reasons that the traditional standard
ordinarily guarantees that only reliable scientific evidence will be
admitted do not apply to new blood procedures. Instead of using
the traditional legal test, the new procedures should be admitted
into criminal trials only after comprehensive scientific experiments
have proven that the genetic marker evidence is reliable.
A. The Frye Standard
In 1923, the Court of Appeals for the District of Columbia de-
cided Frye v. United States.40 In rejecting the admissibility of
polygraph evidence, the court held that:
Just when a scientific principle or discovery crosses the line
between the experimental and demonstrable stages is difficult
to define. Somewhere in this twilight zone the evidential force
of the principle must be recognized, and while the courts will
go a long way in admitting expert testimony deduced from a
well-recognized scientific principle or discovery, the thing
from which the deduction is made must be sufficiently estab-
39 See BLOOD GROUP, supra note 11, at 407; Baird, supra note 1, at 113, 115.
40 293 F. 1013 (D.C. Cir. 1923).
1982]
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lished to have gained general acceptance in the particular
field in which it belongs.41
The precise status of this test for determining the admissibility
of novel scientific evidence is not entirely clear. Some jurisdictions
have accepted it; some have rejected it; others have modified it;
and still others have stated that they were applying it even though
their decisions implicitly ignored it. It is clear, however, that this
1923 language has shaped the debate over the proper standards for
admitting new scientific techniques,42 and that "the Frye test has
dominated the admissibility of scientific evidence for more than
half a century. 43
As the mixed reactions should indicate, the Frye requirements
have their critics. Indeed, the attacks have been labelled "scath-
ing.",44 The test has been characterized as vague and therefore dif-
ficult to apply.45 One court has stated that the Frye standard "is
usually construed as necessitating a survey and categorization of
the subjective views of a number of scientists. . . but a determina-
tion of reliability cannot rest solely on a process of 'counting (sci-
entific) noses.' ,4' The strongest criticism, however, is that the test
keeps reliable evidence from the jury. Although a new scientific
procedure might be proven reliable, the Frye standard suppresses
such evidence until the scientific community has taken the time to
pass judgment on the reliability of the procedure. The critics con-
tend that this delay between proven reliability and scientific con-
sensus denies the court from ruling on valuable evidence. 7 In
41 Id. at 1014.
42 For an excellent discussion of the current status of the Frye test, see Giannelli, The
Admissibility of Novel Scientific Evidence: Frye v. United States, a Half-Century Later, 80
COLUM. L. Rav. 1197, 1228 (1980).
43 Id. at 1205.
" Id. at 1206.
45 Id. at 1223. See also United States v. Williams, 583 F.2d 1194, 1198 (2d Cir. 1978), in
which the Second Circuit states that the "[d]ifficulty in applying the Frye test has led a
number of courts to its implicit modification."
46 583 F.2d at 1198. The Williams court stated that "[in testing for admissibility of a
particular type of scientific evidence, whatever the scientific 'voting' pattern may be, the
courts cannot in any event surrender to scientists the responsibility for determining the
reliability of that evidence." Id.
47 See Giannelli, supra note 42, at 1223.
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other words, even though "every useful new development must
have its first day in court,"' 8 the Frye test delays that day longer
than is necessary.
Defenders of Frye admit that the test erects a difficult standard
that delays the admission of scientific evidence:
This obviously sets forth a standard that is neither common
to criminal litigation nor easily applied in the individual case.
Equally obvious, the Frye standard retards somewhat the ad-
mission of proof based on new methods of scientific investiga-
tion by requiring that they attain sufficient currency and sta-
tus to gain the general acceptance of the relevant scientific
community.49
A conservative approach is warranted, defenders maintain,
"[s]ince scientific proof may in some instances assume a posture of
mystic infallibility in the eyes of a jury of laymen. . . . ,5 The
chief advantage of the Frye test is that reliability of the new proof
virtually is guaranteed since "the requirement of general accept-
ance in the scientific community assures that those most qualified
to assess the general validity of a scientific method will have the
determinative voice." 51
While these arguments may be representative of the debate over
the admissibility of scientific evidence, both sides overlook an im-
portant point. Both proponents and detractors of Frye agree that a
stringent legal standard assures that a scientific test is reliable
before it is admitted. One side believes Frye delays admissibility
until too long after reliability has been proven, while the other be-
lieves caution is necessary to prevent lay jurors from giving techni-
cal evidence undue weight. As this author shall demonstrate, how-
ever, the Frye standard is insufficient to assure reliability in the
case of the genetic marker tests. Whether these forensic procedures
are reliable or not, Frye admits them. Since reliable evidence is the
goal and since Frye does not serve that purpose here, a different
48 See United States v. Stifel, 433 F.2d 431, 438 (6th Cir. 1970).
49 United States v. Addison, 498 F.2d 741, 743 (D.C. Cir. 1974).
:o Id. at 744.
61 Id. at 743-44. See also People v. Kelly, 17 Cal. 3d 24, 31, 549 P.2d 1240, 1244-45, 130
Cal. Rptr. 144, 148 (1976); Giannelli, supra note 42, at 1205-07.
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admissibility standard is needed for these procedures.
B. Why Frye Normally Works
Frye rests on the notion that science is a never-ending construct.
A scientific discovery does not stand alone; instead, each new piece
of knowledge is a block upon which others will build. Before that
new building block is put into service, however, it is tested in a
disinterested way to make certain that it is sound. If somehow an
unsound piece slips through, it will be discovered as others try to
use it.
Because this is the nature of science, a new scientific procedure
will normally go through a three-step process: first, the procedure
is developed, then other scientists will test the results, and finally,
if the procedure is sound, general use of it will follow. Only at the
end of this process is the reliability of the procedure clearly estab-
lished. Suppose, for example, that some types of blindness are
caused by tiny blood vessels in the eyes wearing out and bursting.
This results in enough bleeding in the eyeballs to cause pressure
that results in the deteriorating eyesight. A scientist believes that
this condition could be arrested by the sealing of those capillaries.
Working on animals, he develops a laser surgery technique that he
believes can stop the bleeding without doing damage to the rest of
the eyeball. He publishes his results.
Other eye specialists reading this report may be impressed by it,
agree with the theory behind it, and understand how the new pro-
cedure should alleviate the condition. They would not yet, how-
ever, accept the procedure as reliable. Instead, verification through
the use of controlled studies would next be required. Two sets of
patients with the condition would be needed, one set to receive the
new treatment, and one control set. This would be done for two
reasons: first, to see if the procedure worked the cure as claimed;
and second, to see if any limitations, such as side-effects, could be
discovered. Such dangers, of course, should be identified before the
technique goes into general practice.
If the new procedure passed the controlled studies, it might be
regarded as reliable, but the best guarantee of reliability is still to
come. The ultimate test would be the actual use of the technique
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in general practice. Any limitations that were not unearthed in the
studies would surface as the procedure was used under various cir-
cumstances. It might eventually be learned that while the surgery
at first seems to be successful with diabetics, after a year or so the
blood vessels burst again causing greater problems than before.
Certainly, only when a procedure has gone through these three
steps-development of the methodology, verification of the
claimed results, and actual employment of the new technique-
can the community of concerned scientists know both the proce-
dure's reliability and its limitations.
Of course, not all scientific discoveries have the immediate
clinical impact of this posited eye surgery. One can expect that any
procedure affecting the health or safety of humans would undergo
rigorous verification before it were used. That is not to say, how-
ever, that other discoveries would not have to mount similar steps
to test their reliability and limitations. A group of scientists, for
example, may be concerned with trying to learn how the nervous
system develops in a fetus. At present, basic research is being con-
ducted in laboratory animals in an attempt to learn about the bio-
chemicals that relay "messages" from one nerve to another. Sup-
pose one scientist believes he has perfected a more efficient way to
detect minute amounts of one such chemical, for example,
norepinephrine, in the tissue of rats. This new assay may not have
any immediate human or clinical applications, but if it is truly the
advance the developer hopes for, other scientists working in his
field would also want to use it. These other scientists, however,.
may insist on verification of his work before they use the new pro-
cedure. Though human health may not be an immediate concern,
the time, effort, and integrity of the scientists would be at stake.
Finally, the ultimate check on the reliability and the limitations on
the novel assay would become apparent as the technique was used
by other scientists. This check would arise naturally because the
detection of the chemical is not an end in itself. Instead, the scien-
tists would view the chemical detection merely as one step in fur-
thering the understanding of the developing nervous system. If for
some reason the new assay delivered authentic looking results that
were actually spurious, this would become known as scientists ex-
panded their knowledge by unknowingly relying upon the inexact
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procedure.
For example, a scientist may be studying the effect of nicotine
ingestion by pregnant mothers on the developing fetus. In this ba-
sic research, nicotine is given to pregnant rats, and tissues nor-
mally known to contain norepinephrine are examined in the fetal
rats. As a matter of convenience, in the past this scientist freeze-
dried the tissues when obtained and stored them until a large
batch had been collected. The scientist usually found it more eco-
nomical to run the assays on many tissues at once than on each
when taken separately. With the old procedure, this method pro-
duced no problems. Assume that the new assay, however, performs
perfectly on fresh tissues, but for some reason does not work on
those that have been frozen, and this limitation is not yet known.
The scientist using this new procedure may think that he has dis-
covered that the nicotine ingestion in the mother inhibits the pro-
duction of the biochemical in the fetus. This presumably would be
an important finding, and that scientist or others would want to
build on this knowledge. Other experiments would follow. Similar
work would perhaps be done, and other nervous system chemicals
would be examined. The scientist might try to see if it mattered at
what point in the pregnancy term the mother ingested the nico-
tine, or if the ingestion of lesser amounts of nicotine did not pre-
vent the production of norepinephrine, or at what point in its de-
velopment the fetus stopped producing that chemical. Further
experiments likely would occur, and sooner or later someone work-
ing in the field might discover that the fetus actually had been pro-
ducing the substance and that the originally reported results were
wrong because the new assay did not work under these
circumstances.
The ultimate guarantor of reliability in both these examples,
then, is that the new test is put into practice and this practice
eventually shows whether the procedure is unreliable or has limita-
tions. The test creates incentives to check the reliability and limi-
tations of the procedure before it becomes widespread. When a
procedure has become so widely used in a field that any flaws in
the procedure would have become known, the courts can conclude
that not only has the new test been accepted as reliable by the
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relevant scientific community, but that the test also is reliable.
The basic notion behind the Frye test, then, is a good one. Once
a procedure is sufficiently established to have gained general ac-
ceptance in the particular field in which it belongs, it presumably
has gone through an extended period of use and testing within the
scientific community and is reliable. The question that naturally
arises, however, is whether the typing of blood by the new forensic
procedures is subject to the same dynamics as other new scientific
tests?
C. The Frye Test Does Not Guarantee Reliability of the Genetic
Tests
Unlike most scientific procedures, those used to detect genetic
markers in dried blood will not, through repeated use, assure the
validity and reliability of the procedures.52 In contrast to the errors
of other scientific investigators, the errors of the forensic serologist
will not invariably become known. Unlike the use of most scientific
tests, the detection of genetic markers in the forensic laboratory is
the ending point; these results are not employed by scientists in
ways that would invariably reveal limitations of the procedure.
Clinical practice does not need the tests of the criminal investi-
gator since the procedures are not used in the treatment of pa-
tients. In fact, the role that many of the polymorphic enzymes play
in the body is still unknown.53 Even when the function has been
discovered, the clinician still may not be interested in the details
provided by forensic tests. Thus, in treating a person with a meta-
bolic problem, it is conceivable that a doctor may want to know
whether PGM is present in that person in normal amounts. While
that doctor might be concerned with the levels of PGM, however,
82 In scientific terminology, "validity" and "reliability" have different definitions. "'Va-
lidity' refers to the ability of a test procedure to measure what it is supposed to measure-
its accuracy. 'Reliability' refers to whether the same results are obtained in each instance in
which the test is performed-its consistency. Validity includes reliability, but the converse
is not necessarily true." Giannelli, supra note 42, at 1201 n.20.
53 For example, although it has been discovered that PGM and AK both act as catalysts
in the metabolism of sugars, the precise function of EAP is not known. See DISTRiBUTION OF
HUMAN BLOOD GROUPS, supra note 25, at 38, 41; Baird, supra note 1, at 109, 113.
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he does not care which of the polymorphic forms that enzyme
takes. All the variants of PGM perform the same function in the
body.54 PGM "2" does the same as PGM "2-1." Consequently, the
doctor might run tests to see how much PGM is present; he will
not have any reason to find out what kind of PGM it is. 5
Although clinical practice is not concerned with the polymorphic
form a blood constituent may take in an individual, there is con-
cern with how the blood of one person may react when put into the
body of another-when there is a transfusion. Transfusion reac-
tions, however, are only caused by the antigen-antibody systems. 5
The substances detected by electrophoresis do not have any ad-
verse transfusion consequences. It does not matter if blood with
PGM "1" is put into a patient with PGM "2-1. '5 It does matter,
of course, if a person with type "B" blood gets a transfusion of
type "A" blood because agglutination and possible death would re-
sult. Consequently, if an unreliable test for typing the ABO groups
were used, a blood bank would quickly find out. Thus, the reliabil-
ity of the blood bank's test is assured by its use.
The blood bank's procedures, however, are not those used by the
forensic scientist.58 It cannot be stressed too much that the foren-
sic laboratory will deal with dried blood-blood that has aged in
For a discussion of the polymorphic characteristics of blood, see supra text accompa-
nying notes 25-27.
51 Even if the doctor had run tests to determine which form that enzyme took, he
would not know from his clinical work whether the tests to classify the genetic markers gave
valid results since there would be no consequences for his patient if, for example, PGM "2-
1" were incorrectly classified as "2."
56 See Baxter, supra note 2, at 284 & n.2.
57 Important forensic consequences might occur from such a transfusion. Culliford
notes that a victim of an assault who has PGM "1" may get a transfusion of blood with
PGM "2." He goes on to state that "this will not harm the patient but could make a blood
sample taken as a control from the victim unreliable for forensic purposes." B. CULLIFORD,
supra note 3, at 38. In other words, the classification of genetic markers of someone who has
recently received a transfusion may be wrong. Culliford states that the forensic laboratory
should know if such a transfusion occurred, and if so, should try instead to type a pre-
transfusion sample of blood from the victim or wait four to six weeks to classify the victim's
genetic markers. Id.
58 The blood bank normally only tests for two systems: "The routine blood grouping
tests in the normal clinical work are limited to the four A-B-O groups and the Rho blood
factor.... [Other antigen tests] are not included in the ordinary tests for matching blood
for transfusions." 2 AM. JUR. PROOF OF FAcTs, Blood Types 279 (Supp. 1981).
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ways not controlled by the serologist. The blood bank, however,
does not use the procedures of the forensic scientist because it has
no interest in identifying blood groups in dried blood. Those con-
cerned with transfusions have no stake in trying to identify the
type of blood found dried on a defendant's sweater. Rather, the
blood bank merely types a liquid substance, either fresh blood or
liquid blood preserved under known conditions.
The forensic scientist stands alone in the attempt to classify ge-
netic markers in dried blood,"9 and thus, those tests have not been
validated by use or research in other scientific areas. Furthermore,
the forensic scientist does not put his results to a scientific use that
would invariably show the limitations and liabilities, if any, of the
procedures. When the forensic laboratory classifies a blood sam-
ple's PGM into one of its genetic variants, this classification is not
merely a research step upon which that forensic scientist or others
will continue to build. The scientist's job, conversely, ends with
that categorization rather than putting these findings to any fur-
ther use. Consequently, if for some unknown reason the procedures
to detect genetic markers in dried and aged blood falsely detect
PGM "1" as "2-1," this incorrect result will not necessarily be dis-
covered by any subsequent scientific use or practice.
For purposes of the Frye test, this means the detection of ge-
netic markers in dried blood is different from other scientific pro-
cedures. Acceptance by the relevant scientific community normally
means that a procedure has been employed in such a way that the
procedure's reliability would become known. This is not true for
the forensic detection of genetic markers because these procedures
are not used in ways that would reveal any limitations. The relia-
bility of these forensic tests can only be shown from controlled ex-
periments. Therefore, the Frye standard, which relies on the gen-
eral acceptance of a test to affirm that test's reliability, does not
serve its purpose. Mere widespread use of the forensic procedures
proves nothing about their trustworthiness. Furthermore, an addi-
tional compelling argument why Frye should not be applied to the
5" Genetics is the other branch of science that studies polymorphisms. The geneticist,
however, does not have an interest in classifying genetic markers in dried blood. Instead, he,
like the blood bank, works with fresh or preserved liquid blood.
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genetic marker test derives from the unique nature of the field that
uses these tests.
D. Problems Concerning the Genetic Marker Field
Before results of a test can be admitted into evidence, Frye, of
course, requires that the test be generally acceptable in the rele-
vant scientific field.60 What then, is "the field" for these genetic
marker procedures? The only field in which the tests for genetic
markers in dried blood have been generally accepted and used
happens to be a group with special characteristics. As we have
seen, although several areas of science or medicine may be inter-
ested in genetic markers, only one attempts to detect them in dried
blood.
The relevant scientific field does not contain all of the sciences
concerned with blood. If it did, the tests could not be considered
generally acceptable because only a small percentage of that group
has any interest whatsoever in the detection of genetic markers.
The field does not even encompass the entire subset of scientists
who study genetic markers-a subset that contains blood bankers,
geneticists, and doctors interested in such areas as metabolism or
transfusions. The forensic tests are not established throughout this
field, either, because, as we have seen,"1 this group is not concerned
with the detection of genetic markers in dried, aged blood.
Rather, the tests for the detection of genetic markers in dried
blood can possibly be accepted in this field only if that field is de-
fined as a subset of the subset - those who study the detection of
genetic markers in dried blood. 2 That field becomes a quite special
60 See Giannelli, supra note 42, at 1205.
*1 See supra text accompanying notes 53-59 for a discussion of the differing emphasis
that criminal investigators, doctors, and blood bankers place on various blood testing
procedures.
62 In the leading case of People v. Williams, 164 Cal. App. 2d 858, 331 P.2d 251 (1958),
the court defined the field in a similar way to allow the admissibility of the Nalline test, a
procedure for the detection of narcotics in a person. It was conceded "that the medical
profession generally is unfamiliar with the use of Nalline and therefore it cannot be truth-
fully said that the Nalline test has met with general acceptance by the medical profession as
a whole. ... "Id. at 862, 331 P.2d at 253. The court, however, went on to admit the test
by concluding that "[i]t has been generally accepted by those who would be expected to be
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one, consisting only of forensic scientists, or more precisely, the
fraction of forensic scientists concerned with blood.
This specialized field has two important characteristics that
ought to give a court pause before it accepts this group's certifica-
tion that one of its forensic procedures is reliable. First, it is a
small field. Not many scientists fall into the category of forensic
serology. 3 An implicit foundation of the Frye standard is that a
court can be assured of a scientific procedure's reliability if a large
number of scientists accept the procedure. "If the 'specialized field'
is too narrow, the consensus judgment mandated by Frye becomes
illusory; the judgment of the scientific community becomes, in re-
ality, the opinion of a few experts." 4
Second, the field of forensic serology is almost entirely composed
of law enforcement professionals. The only people trying to detect
genetic markers in dried blood are forensic scientists, and these
scientists are almost exclusively either employees of law enforce-
ment agencies or are funded by such governmental bodies.e5 One
could hardly classify this group as impartial on the question of the
reliability of the techniques it uses. Indeed, many, if not most,
have a stake in convincing a court that their tests are reliable since
the significance of their work and careers would be greatly deval-
ued if the evidence were barred from criminal trials.
A corollary is that the evidence about reliability and acceptabil-
ity will only be presented by one of the adversaries at the trial.
The characteristics of the community interested in the detection of
familiar with its use. In this age of specialization more should not be required." Id. at 862,
331 P.2d at 254. For a discussion of the identification of the appropriate field using the Frye
standard, see Giannelli, supra note 42, at 1208-10. See also United States v. Williams, 583
F.2d 1194 (2d Cir. 1978), in which the court, in considering whether it was proper to admit
spectographic voice-identification evidence, stated that "Es]election of the 'relevant scientific
community,' appears to influence the result" of determining whether such evidence has been
accepted as reliable. Id. at 1198.
63 Although people may classify themselves as forensic serologists, there is no certifica-
tion process for a forensic serologist. Letter from Dr. B. W. Grunbaum to R. Jonakait (July
18, 1981).
Giannelli, supra note 42, at 1209-10.
e' Much of the research into the detection of genetic markers was funded by the Law
Enforcement Assistance Administration. See infra note 135 for a discussion of the LEAA
practice of not funding verification studies.
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genetic markers in dried blood indicates that the defense may have
a difficult time finding a qualified person to analyze evidence from
the defendant's viewpoint. Justifying the use of the Frye standard,
one court observed that "the Frye test protects prosecution and
defense alike by assuring that a minimal reserve of experts exists
who can critically examine the validity of a scientific determination
in a particular case. '"6 This reserve of experts, however, does not
exist here. Instead, the composition of this scientific field indicates
that normally the evidence will be presented and analyzed only by
someone from a small group of people, all of whom have a prosecu-
tion perspective.
This does not mean, of course, that this group's conclusion as to
the reliability of its procedures would necessarily be incorrect or
biased. A court, however, should be aware of forensic serology's as-
sertion that the tests are reliable and valid is really the conclusion
of the few and the partisan. Under such circumstances, it is only
fair to insist that the courts carefully analyze the claim of reliabil-
ity. The history of the paraffin test affords a valuable illustration
and warning.
E. Lessons from the Paraffin Test
In 1933, Mexican Theodora Gonzalez announced a procedure to
determine whether a person had recently fired a gun.67 "The the-
ory behind the test was that the results established the presence of
particles of nitrates or nitrites, deposited on the hand by the bases
of a discharged cartridge."6 8 The popular name for the test-the
paraffin test-evolved because hot paraffin was 'applied to the
hands. It was believed that this substance caused "the pores of the
skin to open up, [mixed] with the oil in the pores, and [caused] the
pores to exude the gunpower residues imbedded therein."6
Enough paraffin was applied until "a paraffin glove [was] finally
molded, which, when cooled, [was] peeled gently from the
United States v. Addison, 498 F.2d 741, 744 (D.C. Cir. 1974).
67 A. MOENSSENS & F. INBAU, supra note 10, at § 4.12.
68 Id.
69 Conrad, Evidential Implications of the Dermal Nitrate Test for Gunpowder Resi-
dues, 44 MARQ. L. REv. 500, 503-04 (1961).
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hand. . . .An organic reagent, diphenylamine. . . [was] added to
the paraffin glove drop by drop. A positive reaction indicating the
presence of gunpowder residues [was] indicated by the appearance
of dark blue pin-point specks on the inner surface of the case." 70
After its introduction, "the paraffin test was adopted quickly by
law enforcement agencies," with the first reported case upholding
the admissibility of this test decided in 1936.71 Although reported
cases on the procedure were nonexistent for the next generation,
"the procedure was in general use in courts on a trial level."72
Experts were probably testifying at trial that the paraffin test
was reliable and was generally accepted in its scientific field. For
the same reasons presented above, however, hindsight shows us
that the courts should have questioned these assertions. The paral-
lels between the paraffin test and the genetic marker tests are
close. First, like the dried blood procedures, scientists did not use
the results of the paraffin test in such a way that any inherent un-
reliability would inevitably be discovered. No one besides forensic
scientists would have been interested in this procedure. In actual-
ity, for the forensic scientist, the tests were ends in themselves.
Like dried blood testing, the detection of gunpowder residues was
not a block upon which other research was built-research that
would have exposed the limitations of the test. Thus, the paraffin
test, like the dried blood procedures, never faced this strongest
guarantor of reliability.
Second, as with the dried blood tests, generally the experts all
would have been forensic scientists since they would be the only
ones familiar with the tests. This meant that the evidence about
reliability again would come only from a small number of people
all with bias toward one side of the question. As with the forensic
tests for genetic markers, reliability could truly be established only
if careful experimentation were done to discover the test's limita-
70 Id. at 502.
71 See Giannelli, supra note 42, at 1224. The first case upholding the admissibility of
the paraffin test was Commonwealth v. Westwood, 324 Pa. 289, 188 A. 304 (1936) (paraffin
test admitted to show gunpowder residue on defendant's hand). See Conrad, supra note 69,
at 507-09, for a discussion of Westwood.
7 Conrad, supra note 69, at 509.
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tions. Such a study was finally undertaken, although it was not un-
til 1967 that the first comprehensive study was published. 3 This
research showed that the paraffin test was unreliable because it
gave positive results for many people who had never fired a gun.74
Even though it is now recognized that this test is not valid because
of the false positives,75 "evidence based on the test was admitted in
trials throughout the 1960's."76
Because of the lapse of time until the fallibility of the test was
discovered, jurors, for over thirty years, were told that they could
base their verdicts on what turned out to be unreliable evidence.1
This evidence was admitted because courts accepted the assertions
of forensic scientists about the tests. The scientists made those as-
sertions even though comprehensive reliability studies had not
been done. When such research was produced, the forensic scien-
tists' confidence in their procedures was shown to be egregiously
misplaced. This history should give pause to any court faced with
the admissibility of the procedures claimed to detect genetic mark-
ers in dried blood. As will be discussed, the blood tests now stand
where the paraffin tests stood before the comprehensive reliability
studies were done.
Frye, with its premium on general acceptance in a scientific
field,,does not guarantee reliability of the genetic marker proce-
durep that are used solely by forensic scientists and not used to
73 See GianneUi, supra note 42, at 1224-25, for a discussion of the first thorough evalua-
tion of the paraffin test.
74 Research discovered that many people who never fired a gun but whose profes-
sion, occupation, or happenstance brought them in contact with nitrates can be
expected to yield positive reactions to the test. Among them are photographers,
engravers, match workers, farmer[s] and gardener[s] handling fertilizers, etc.
Other substances which may be expected to yield positive tests include bleaching
agents, chemical[s], cosmetics, explosives, certain types of foodstuffs, tobacco, and
urine.
A. MOENSSENS & F. INBAU, supra note 10, at § 4.12. In contrast, another scientist contends
that the test is sufficiently reliable to be admitted into evidence. See Conrad, supra note 69,
at 504-06.
75 See Stone, Evidence of Firearms Discharge Residues, 33 BAYLOR L. REv. 285, 286
(1981).
76 Giannelli, supra note 42, at 1225.
7 Since evidence as to whether a defendant fired a gun might be crucial evidence in
many murder trials, this unreliable evidence might also have helped lead to executions.
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further a research scheme or in any practical way that would reveal
their limitations. The reliability of such tests could only be assured
if comprehensive experimentation were done to study that reliabil-
ity. Therefore, before these forensic techniques are admitted into
criminal trials, courts ought to require that such comprehensive re-
liability studies be presented.
III. THE BURDEN OF PROOF ON RELIABILITY
Courts that have admitted the new blood tests have not required
that the tests themselves be established as scientifically reliable.
Instead, these courts have placed upon the defendants the burden
of proving the tests unreliable-something extremely difficult for
defendants to establish. This portion of the paper will advocate
that in order to guarantee the admission of trustworthy evidence,
the burden of proving the tests reliable should be placed on the
prosecution.
A. The Courts' Approaches
Assertions that the procedures for the detection of genetic mark-
ers in dried blood are reliable or accepted by the scientific commu-
nity are less valuable than such assertions about other scientific
techniques. Unlike other procedures, these tests for genetic mark-
ers do not have their reliability examined through their constant
use in a practical way or in any continuing research. Rather, the
assertions about the worth of the procedures come from a small
group of interested people. The history of the paraffin test indi-
cates that concerns over reliability are not merely abstract con-
cerns, but instead are factors which should trigger a close look at
the fallibility of the tests before they are admitted into criminal
cases. Unfortunately, the courts, in the few cases that have actually
litigated the admissibility of the techniques, 8 have not recognized
these considerations, much less the importance of them. A look at
several cases illustrates this.
73 See supra note 8 for a list of cases in which the blood grouping tests were introduced
by the prosecution.
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In Robinson v. Statee79 the defendant was convicted of assault
with intent to murder. The victim was severely cut on the throat
and face. The defendant, when arrested approximately an hour af-
ter the attack, had blood on his clothes. At trial, the court permit-
ted Jean Hostetler, a forensic chemist from the Montgomery
County Police Department,"° to testify that she analyzed the vic-
tim's blood as well as the blood on defendant's trousers using
traditional ABO tests and electrophoretic procedures. 81 The blood
samples matched each other.
The Robinson appellate court stated that "the only significant
objection" to the admission of the genetic marker evidence was
that
Ms. Hostetler's testimony only established that the use of
electrophoresis and enzyme comparison for the purpose of
classifying blood samples is an accepted practice in the field
of forensic chemistry. She did not and could not, according to
appellant, demonstrate that this technique is generally ac-
cepted in the broader scientific community.82
This objection did not matter. The court stated that Maryland's
interpretations of the Frye rule did not require "that a scientific
technique be deemed legally unreliable simply because that tech-
nique has obtained general acceptance in only one branch of sci-
ence."' 83 The court concluded further that the testimony gave "an
adequate foundation for. . . the trial court's ruling that the tech-
nique is accepted as reliable within the field of forensic
79 47 Md. App. 558, 425 A.2d 211 (1981).
80 Id. at 573, 425 A.2d at 219.
81 The opinion does not indicate which genetic markers were classified by
electrophoresis.
82 47 Md. App. at 575, 425 A.2d at 220. The court noted that on cross-examination, the
state's witness stated
that the electrophoretic technique at issue here is not typically used by hospital or
other non-police labs. However, she explained that the reason for this is that en-
zyme structure does not affect blood compatibility for the purposes of transfusions
and the like; therefore, aside from use in forensic and research labs, there is sim-
ply no need for the precision that this technique affords.
Id.
8Id. at 576, 425 A.2d at 220.
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chemistry. ' s4
Since the court seemed to accept the conclusion that these tests
were used almost exclusively in police laboratories, s5 the court was
effectively stating that if the scientists employed by the law en-
forcement agencies testify that the test is reliable, then the evi-
dence should be admitted." Not considered by the court was the
quite special nature of such a field and whether that field's unique
attributes might affect its conclusions about a scientific procedure.
In addition to finding forensic chemistry to be the relevant field,
the Robinson court found two bases for the conclusion that that
field accepted the tests as reliable. The affirmative assertions of
the witness formed one support:
As to the reliability of the described electrophoretic tech-
nique, Ms. Hostetler testified that it was developed in the late
60's and that it is now an accepted practice in the field of
forensic chemistry. She testified further that she personally
knew that electrophoresis was being utilized by the Mont-
gomery County Police, the Baltimore Police, the Maryland
State Police and the Federal Bureau of Investigation .... 87
The lack of contradictory evidence by the defense was the sec-
ond basis for the court's conclusion: "Ms. Hostetler's testimony
was uncontroverted. No expert witness was called by the defense,
- Id. at 576, 425 A.2d at 221.
:5 See supra note 82.
11 Compare the Robinson court's conclusion about the relevant field with People v. Bar-
bara, 400 Mich. 352, 255 N.W.2d 171 (1977), in which the court rejected the admission of lie
detector evidence. The Michigan Supreme Court in People v. Barbara analyzed other court
decisions that found general acceptance of the lie detector. The court then concluded that:
[I]n order to find such acceptance, these courts adopted what was in fact a
logical fallacy.
Under the present state of the art the general acceptance of the polygraph
among psychologists and physiologists cannot be demonstrated, because such ac-
ceptance does not exist. Therefore, these courts, in order to find general accept-
ance, found it amongst polygraphers. Once finding general acceptance, the courts
then found they did not have to rely on scientific testimony, but were able to rely
on the testimony of polygraphers to establish reliability of the device.
Such reasoning is circular ....
Id. at 390, 255 N.W.2d at 187.
97 47 Md. App. at 575, 425 A.2d at 220.
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nor was any other evidence adduced to suggest that electrophoresis
is regarded as either experimental or controversial.""" The court
never analyzed whether these two purported bases in fact tended
to show that the tests were reliable. If it had, the court should have
seen that this foundation was flawed.
While the witness stated that the tests were accepted by forensic
chemists, her opinion gave no explanation of why it was so ac-
cepted. Significantly, nothing was cited to show that the tests were
reliable. No reference was given to any of the relevant literature.
The statement that the procedures were accepted by the forensic
scientists was the equivalent of stating that many forensic labora-
tories use the procedures.8
Widespread use, however, does not necessarily equal reliability.
Many forensic labs used the paraffin test, but that did not mean
that the procedure was accurate. Such verification requires con-
trolled experiments, and controlled experiments require time and
money. Few forensic laboratories are in business to do such re-
search. Most exist to give answers to law enforcement agencies
about specific pieces of physical evidence.
A forensic procedure becomes widespread not because all the
people using it have made independent evaluations about reliabil-
ity. Instead, a few research scientists develop the procedure. If the
new technique appears to work, then the methods are taught to
others. Since few labs can afford to employ only highly trained
scientists, -often those learning the procedures are not scientists,
" Id. at 576, 425 A.2d at 220.
8 The lack of evidence on these points might have resulted because the witness was not
a scientist, but merely a technician. One commentator has concluded that technicians
should be limited in their testimony.
[A] technician's testimony should never suffice to establish the validity of a novel
technique: "[Tihe technician merely follows prescribed routines, and is not ex-
pected to understand their underlying fundamentals. He knows how, but not
why." Kirk, The Interrelationship of Law and Science, 13 BUFFALo L. REV. 393,
394 (1964). Because it is critical to know the 'why,' or, as in the case of empirical
validation, the implications of not knowing the 'why,' the views of scientists are
essential. Moreover, a technician would not be qualified to testify about the gen-
eral acceptability of a technique because presumably only a scientist would be
sufficiently conversant with the views held by those in the relevant field.
Giannelli, supra note 42, at 1214-15 (footnotes omitted).
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but technicians. Thus, most of those who use the new tests have
not verified the test's reliability, and few would have the training
to conduct such research in any event. The users of the procedure,
then, trust that the procedure is reliable, not because they have
verified that fact but because the developers of the procedure say
that it is reliable. Widespread use of electrophoretic tests in foren-
sic labs thus does not indicate anything more about reliability than
that a handful of people have attested to their reliability.
The Robinson court also stressed that the defense presented no
experts of its own or other evidence to show that electrophoresis
"is regarded as either experimental or controversial" in justifying
the procedures' admission into the criminal trial.9" This is shoddy
reasoning. As one commentator has stated about different, but also
controversial scientific evidence, "Incredibly, several courts have
cited the absence of opposing experts to support their decision to
admit voiceprints, apparently inferring reliability from a lack of
opposition. This inference is unwarranted." 91 The inference is
wrong for several reasons. A defendant may not have the means to
present such a rebuttal. Defendants often are poor and may not
have access to laboratories and experts. The prosecution, however,
does not face this handicap. States and most large metropolitan
areas have government-operated forensic laboratories. Federal lab-
oratories likewise provide services to local and state law enforce-
ment agencies. 92 The FBI lab will do forensic tests for local agen-
cies without charge and even provide for the court appearance of
the expert. 3
Even if the defense has money to spend on experts, it will en-
counter difficulties in finding a person willing to probe the evi-
dence from the defense's viewpoint. The defense cannot just go to
the local forensic serologist to discuss the issues. Very few people
are familiar with this evidence, and, as discussed above, almost all
are connected with law enforcement agencies. Under these circum-
stances, the lack of opposing evidence at trial may not indicate re-
10 47 Md. App. at 576, 425 A.2d at 220.
11 Giannelli, supra note 42, at 1243.
:2 Id. at 1244.
3 Id.
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liability, but rather only the narrowness and one-sided composition
of the field.94
The Robinson approach implicitly states that once the prosecu-
tion comes forward with some evidence of reliability, however fee-
ble, then the burden of proof shifts to the defendant. In Robinson
the prosecution's production burden was met merely by introduc-
ing evidence that the genetic marker tests are widely used in the
forensic field. Since the defendant produced no evidence, it was
reasoned that the tests should be admitted. Most important in this
approach is that the prosecution has to present no evidence that
the tests are reliable other than the fact that a small band of peo-
ple say they are.
Reasoning like that in Robinson also held sway in People v.
Young,95 even though the Michigan court professed to be applying
9 Of course, even if the defense does manage to have access to experts, the adversary
system can only work properly if the defendant is given ample notice and discovery of the
prosecution's test. See Giannelli, supra note 42, at 1240; Annot., supra note 9, at 509. A
corollary duty should require the prosecution to preserve the evidence so that the defense
can retest it. See Giannelli, supra note 42, at 1243. Thus, in People v. Nation, 26 Cal. 3d
169, 604 P.2d 1051, 161 Cal. Rptr. 299 (1980), the California Supreme Court held that the
prosecution has the duty of preserving a semen sample recovered in a sexual assualt case so
that the defense could later examine the sample for genetic markers. In many criminal
cases, such preservation of forensic evidence, may, however, present a problem. All that
might be recovered are mere flecks of dried blood. Nothing of the evidence may be left after
the prosecution runs its tests. This problem is compounded if the electrophoresis has been
run with a starch gel base since no permanent record is left of these results. The only way of
preserving the starch gel results is through photographs. See Grunbaum, supra note 37, at
54. Fairness to a defendant thus should require that if the prosecution's electrophoretic
tests left no evidence for an independent analysis, then the prosecution should produce clear
and unambiguous photographs of its results so that an independent expert can at least ex-
amine those pictures to see if he would reach the same results as the prosecution's expert.
95 106 Mich. App. 323, 308 N.W.2d 194 (1981). Robinson, Young, and State v. Washing-
ton, 229 Kan. 47, 622 P.2d 986 (1981), which is discussed at infra notes 110-22, are the only
reported cases that give any detailed reasoning supporting the admission of the tests for the
detection of genetic markers in blood. In People v. Bush, 103 Ill. App. 3d 5, 430 N.E.2d 514
(5th Dist. 1982), the defendant challenged the use of the electrophoretic procedures, but did
not make the basis of his challenge clear to the appellate court. The court merely concluded
that, "[c]onsidering the qualifications of the expert, the fact that she was supervised by
senior personnel, and the description of the tests used, we find that proper foundation was
laid for the admission of the evidence." Id. at 13-14, 430 N.E.2d at 521. In Jenkins v. State,
156 Ga. App. 387, 274 S.E.2d 618 (1980), the defendant contended that the testimony con-
cerning the genetic marker test should have been stricken, "basing his motion on a conten-
tion that the reliability of the procedure and the acceptance of the procedure by the scien-
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an evidentiary standard different from the one used in the Mary-
land case. Young was convicted of felony murder. Part of the evi-
dence against him was that an electrophoretic "analysis of defen-
dant's blood revealed properties which corresponded positively to
those of bloodstains found at the [murder] scene."9' 6 This evidence
was presented by Mark Stolorow, "a forensic serologist working for
the Michigan State Police . . . [who] had been active in the re-
search and development of electrophoresis as a technique for com-
paring blood samples. 9 7
Prior to Young, the Michigan Supreme Court had put its own
gloss on the Frye standard in People v. Barbara,9 8 in which the
court held that lie detector evidence was not admissible. "The Bar-
bara court further indicated. . . that the scientific technique used
must be accepted in the particular field in which it belongs and
that such acceptance can be established only by testimony of disin-
terested and impartial experts. . . ,"" The importance of the dis-
interested witness requirement was evident in People v. Tobey,100 a
case in which the Michigan Supreme Court held that voiceprint
evidence should not have been admitted during the criminal trial.
The court pointed to the backgrounds of the two witnesses
presented to establish admissibility and concluded, "Neither Nash
nor Tosi, whose reputations and careers have been built on their
voiceprint work, can be said to be impartial or disinterested."'1 1
Stolorow similarly would not seem to be disinterested in the de-
tific community had not been shown." Id. at 388, 274 S.E.2d at 619. The Jenkins court
disagreed and simply concluded that:
"The opinion of an expert on any question of science is always admissible." Bre-
land v. State, 134 Ga. App. 259 (214 S.E.2d 186). We do not find that the fact that
the procedure is relatively new requires that the testimony be excluded. The wit-
ness explained the procedure, thereby giving the facts on which his opinion was
based. The question, then, is not of admissibility but of the weight to be given the
evidence by the jury.
Id. at 388, 274 S.E.2d at 619.
106 Mich. App. at 325, 308 N.W.2d at 195.
Id. at 325, 308 N.W.2d at 195.
93 400 Mich. 352, 255 N.W.2d 171 (1977).
People v. Young, 106 Mich. App. 323, 327, 308 N.W.2d 194, 196 (1981).
401 Mich. 141, 257 N.W.2d 537 (1977).
101 Id. at 146, 257 N.W.2d at 539.
1982] 863
EMORY LAW JOURNAL
tection of genetic markers in dried blood. The Young court, how-
ever, distinguished the Michigan precedents: "[B]oth Tobey and
Barbara involved scientific devices the accuracy of which was hotly
disputed. Thus, we do not view the Tobey case as extending the
• . . Frye rule to apply to all cases in which scientific evidence is
sought to be admitted. ' 10 2 The court thus concluded "that because,
in the present case, defendant offered no evidence that the electro-
phoresis technique used to compare the blood samples was scien-
tifically inaccurate and because defendant has not convinced us
that the accuracy of electrophoresis is seriously disputed the trial
court did not abuse its discretion in admitting Mark Stolorow's
testimony .... ",03
The impact of the Young decision is that the burden of proof on
the issue of reliability again was given to the defendant, because
the prosecution's evidence that shifted that burden of proof was
the widespread employment of electrophoresis. Here, however, the
witness did not concede a use limited just to forensic science. In-
stead, after explaining the principles of the procedures,
Stolorow testified that the technique of electrophoresis is sim-
ple and dates back many years in the field of biology. He fur-
ther testified that only recently had the technique been
adapted for use with very small samples of bloodstains, but
that the techniques developed were, at the time of trial, em-
ployed routinely in case work .... He further stated that
electrophoresis is used in Red Cross clinics, in hospitals, at
universities, in medical schools, and wherever studies in ge-
netics are performed, as well as in crime laboratories, and
that he personally knew of half a dozen people in Michigan,
not associated with crime laboratories, who performed elec-
trophoresis analysis on a routine basis.'04
The court's summary of the testimony indicates that the judges
were misled. The court appears to have equated use of electrophor-
esis in the places where genetic studies are done with the tests per-
formed by Stolorow. The forensic serologist had grouped the ge-
102 People v. Young, 106 Mich. App. 323, 328, 308 N.W.2d 194, 196 (1981).
2o3 Id. at 329, 308 N.W.2d at 197.
10 Id. at 326, 308 N.W.2d at 195-96.
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netic markers in a bloodstain, not just in fresh blood. The court,
however, never understood that there might be importance in that
distinction. Instead, if the court had been interested in determin-
ing whether the procedure presented in court was reliable, it
should have asked some questions after stating "that only recently
had the technique been adapted for use with very small samples of
bloodstains, but that the techniques developed were, at the time of
trial, employed routinely in case work."10 5
If, for instance, the procedures for the bloodstains are really the
same as for the other electrophoretic procedures, which are "sim-
ple and date back many years,"106 why is it that the techniques for
dried blood have only recently been developed? What is the
"casework" in which the dried blood tests are routinely used? Do
the Red Cross clinics, hospitals, universities, medical schools or
other places doing genetic research use the recently developed
techniques for aged blood? If not, why should it be believed that
the experiences of others working with liquid, fresh blood can be
extrapolated to the tests here with dried blood?
Such questions would have led the court to realize that differ-
ences exist between the tests performed by the forensic expert and
other applications of electrophoresis. The court should have real-
ized that the new procedures for the detection of the markers in
dried blood are only routinely used in police case work. Thus, the
use of electrophoresis by the Red Cross clinics and others was ir-
relevant to the determination of the admissibility question before
the court.107 Reaching this conclusion, the court then should have
asked the most important question: Besides the evidence that the
tests are used by forensic serology, what other evidence is there
that the procedures for the grouping of genetic markers in dried
blood are reliable?
105 Id. at 326, 308 N.W.2d at 195.
106 Id.
107 The court certainly should have realized that just because a scientific test is reliable
in some areas that does not necessarily mean it is reliable in all its applications. See, e.g.,
United States v. Brown, 557 F.2d 541, 557 (6th Cir. 1977), holding that while ion
microprobic analysis had gained acceptance in the field of mass spectrometry, no showing
had been made that technique had been accepted as reliable for comparing hair samples.
See also Giannelli, supra note 42, at 1213.
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The Young case illustrates that unless the defendant can shoul-
der the burden of showing that the tests are unreliable, the fact
that the dried blood procedures are widely used in forensic work
guarantees their admissibility. Interestingly, the Young court con-
cluded that this burden was not met because the "defendant of-
fered no evidence that the electrophoresis technique used to com-
pare the blood samples was scientifically inaccurate and because
defendant has not convinced us that the accuracy of electrophore-
sis is seriously disputed. . . . ,,"0 Apparently, the defense was not
aware of the evidence of any such dispute, although the prosecu-
tion's own expert clearly was. Nothing in the opinion, however, in-
dicates that the prosecution ever brought this evidence to the
court's attention.10 9
Stolorow's knowledge is clear because of his role in the case of
State v. Washington.1 0 Washington was convicted of first degree
murder and rape. Evidence indicated that the assailant had bled at
the crime scene. At trial, Eileen Burnau, "criminalist" for the Kan-
sas Bureau of Investigation, testified that she had analyzed the vic-
tim's and the defendant's blood as well as the blood samples found
at the scene for ABO type and six polymorphic enzyme systems.
108 People v. Young, 106 Mich. App. 323, 329, 308 N.W.2d 194, 197 (1981).
109 Giannelli has argued: "Because the proponent has the burden of proof on the gen-
eral acceptance issue, the proponent should be responsible for informing the trial court of
opposing views in the literature .... "Giannelli, supra note 42, at 1218. While this may be
a noble aspiration, one might question whether this will happen, at least when the only
available experts may be connected with law enforcement agents whose careers will be en-
hanced if the tests are found to be admissible in court. Young certainly indicates that it is
unreasonable to expect the experts to volunteer opposing evidence on their own. Specific
questions probing this possibility would seem to be necessary at least. Of course, only if
there are other experts available who are familiar with scientific literature will it be possible
to check out the accuracy of a prosecution witness' assertion that the scientific literature
contains nothing to indicate unreliability. For instance, in a trial with which I am familiar, a
well qualified forensic serologist testified about the genetic marker tests he had done on a
bloodstain found on the defendant's clothes. On cross-examination he was specifically asked
whether the drying of blood made it more difficult to detect genetic markers. The forensic
serologist just flatly stated, "No." The defense attorney, who did not appear to be knowl-
edgeable about these blood tests and presented no expert testimony of his own, presented
nothing to contradict this incredible assertion. For a discussion of how blood changes
outside the body, see supra text accompanying note 33 and infra text accompanying notes
136-40.
110 229 Kan. 47, 622 P.2d 986 (1981).
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The blood of the victim did not match that of the defendant's,
although some of the blood at the scene did match the defendant's
blood.
The defense challenged this evidence by calling Dr. Benjamin W.
Grunbaum, who, the court said, "possesses an impressive string of
credentials, including bachelors, masters, and doctoral degrees in
biochemistry, and a masters in criminology with a specialty in
criminalistic identification," and had been employed as a research
biochemist at the University of California at Berkeley for 27 years,
specializing in analytical biochemistry and microanalysis, which in-
cludes the examination of body fluids.111 At trial Grunbaum testi-
fied that the tests performed were not reliable:
Specifically, Dr. Grunbaum complained that blood, once
outside the body, is always deteriorating. He explained that
the degradation was particularly acute in the EAP and GLO
enzymes [two of the enzymes typed in the blood samples].
Because of the length of time and the fact that the blood
samples were dry, Dr. Grunbaum testified that the test of the
samples in this case could not be reliable. 112
The genetic markers were detected by a method of electrophoresis
called the Multi-System analysis. According to Burnau, "The
Multi-System analysis is based on the same principles as the other
methods of enzyme analysis, but merely combines the testing.' 11 3
Grunbaum likewise challenged the reliability of this system, noting
that the University of California originally had been involved with
its development, but due to its poor results had withdrawn from
the project. Grunbaum eventually challenged the final results as
having been falsified. Evidence from the Law Enforcement Assis-
tance Administration (LEAA) admitted at the Washington trial
indicated that it had not found support for this claim. The LEAA
concluded that the allegations of test result falsification were un-
confirmed, but still decided not to publish the report. "Grunbaum
also testified that, apart from use in crime laboratories, the Multi-
System analysis was not accepted within the scientific
"I Id. at 50, 622 P.2d at 989.
112 Id.
I's Id. at 58, 622 P.2d at 994.
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community." '14
In rebuttal, the state called Mark Stolorow, who testified that
he, too, had been part of the project that developed the analysis.
He said that the workers had split into two groups. Grunbaum's
group did the electrophoresis with a cellulose acetate base while
the other group used a starch gel base, the one used in the Multi-
System Analysis. Stolorow testified that although the entire re-
search group did EAP readings on both cellulose acetate and
starch gel mediums, "Grunbaum's readings were so inaccurate and
erratic that they were deleted from the report." '115
In contradiction to Grunbaum, the rebuttal witness also went on
to state that the EAP enzyme was less likely to deteriorate in dried
than in liquid form. Although the Washington decision did not
state upon what information Stolorow based this conclusion, the
court observed that his analysis "correspond[ed] to the State's in-
troduction of a booklet called The Detectability of Selected Ge-
netic Markers and Dry Blood Upon Aging published by the Na-
tional Institute of Law Enforcement & Criminal Justice. . . .,,2
Finally, Stolorow asserted that the Multi-System Analysis was reli-
able and was used in over one hundred crime laboratories through-
out the United States and Canada, and that Burnau stated that
the FBI was using it in its laboratory.
In contrast to Stolorow's statements, the court noted that it
could find no reported cases concerning the admission of this evi-
dence. The court concluded that the admissibility should be mea-
sured by the Frye standard and held that:
We have concluded from the record that there was sufficient
evidence of reliability and acceptance by the scientific com-
munity to justify admission of the expert testimony in this
case.. . . We are impressed by the testimony that the Multi-
System analysis is reliable and generally accepted in the
scientific field as illustrated by its present use in over 100
criminal laboratories in this country and that the FBI re-
114 Id. at 51, 622 P.2d at 990.
215 Id. at 51-52, 622 P.2d at 990.
116 Id. at 52, 622 P.2d at 990.
868 [Vol. 31
WILL BLOOD TELL?
search laboratory uses the Multi-System analysis routinely
and approves it. It should be noted that the basis for Dr.
Grunbaum's opinion that the Multi-System analysis was un-
reliable was two-fold (1) that his testing had not produced
one accurate result, and (2) that the EAP enzyme is subject
to rapid deterioration, thus making blood groupings based on
EAP analysis unreliable. This testimony was countered by
testimony that, in testing, Dr. Grumbaum used a different
medium than is used in the [other] method.... As to EAP
enzyme deterioration, the State produced two separate pieces
of evidence showing the contrary-that EAP did not rapidly
deteriorate, once dried.""'
Washington is the only opinion discovered in which the court
made some effort to delve into the actual reliability of the dried
blood genetic marker tests, as well as the only case found in which
the defense presented its own expert. Even so, the approach is still
strikingly similar to that in Robinson and Young; therefore, so is
the result. Once the prosecution establishes that the tests are
widely used by forensic scientists, the tests will be admitted unless
the defendant can convince the court that the procedures are unre-
liable. Since no defendant has carried this burden, the tests have
always been admitted.
A hypothetical will clarify the point. Assume that the same evi-
dence about reliability is produced as was presented in Washing-
ton, but that the evidence also showed that only the Kansas Bu-
reau of Investigation, and no other lab, used these procedures. The
court could not then so glibly pronounce that sufficient evidence of
reliability had been produced. Rather, a battle of the experts
would likely ensue. Under such circumstances, the evidence still
would consist of one expert with "an impressive string of creden-
tials" maintaining that the procedures are unreliable and giving
reasons for that conclusion. On the other hand, another expert
would explain why the developers of the procedure rejected
Grunbaum's complaints. Based on such competing allegations, it is
hard to see how the court could determine who was right.
Certainly, that the developer's report was not published, for
117 Id. at 55, 622 P.2d at 992-93.
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whatever reason, had more significance than the court recognized.
Whether or not the decision to withhold publication indicated any-
thing about the validity of the work, it certainly reflected on the
general acceptance of the study. If the data had not been dissemi-
nated to the scientific community so that an independent examina-
tion and analysis of the findings could be made by any interested
scientist, then the study could not be generally accepted by
scientists.118
The defense in Washington also produced evidence that EAP
deteriorated as it aged. The court rejected this contention, noting
that the state produced two separate pieces of evidence "showing
the contrary-that EAP did not rapidly deteriorate, once dried."119
The court never analyzed the data produced by the two sides to
determine if either of the differing conclusions was supportable or
if one of the conclusions was clearly wrong. The court merely re-
jected the defense's argument by summing up the amount of evi-
dence. If it really were making its decision this way, the court
knocked a hole in the proposition that the quality of evidence
rather than the quantity should decide an issue.
In its tabulation, the Washington court should have been more
interested that only three pieces of evidence were brought to bear
on the question than in the fact that one side outnumbered the
other.120 The court should have wondered whether reliability had
118 This lack of publication should have led to other questions. How is it that, without
the final report, so many labs have used the procedures? Have the one-hundred laboratories
each made independent assessments of the procedure's validity? If so, based on what infor-
mation? Certainly it cannot be the report because it has not been distributed. A plausible
conjecture is that a small group of scientists have taught the others the procedures and told
them that the tests are reliable. Under such circumstances, since the FBI lab teaches the
techniques, id. at 52, 622 P.2d at 990-91, the widespread use of the test would indicate only
that a few people, who happend to be good salesmen, claimed to have had a scientific basis
for their conclusion about reliability.
119 Id. at 55, 622 P.2d at 993.
110 In any event, the court's counting of evidence may have been wrong. The court did
not cite the sources for either Grunbaum's or Stolorow's EAP opinions. Grunbaum's proba-
bly came from his own work. See infra text accompanying note 236. Conversely, I have
found no articles that Stolorow has published concerning EAP deterioration. The Multi-
Systems Analysis, however, was developed jointly by Aerospace Corporation and Beckman
Industries, and Stolorow worked for this Beckman/Aerospace project. See State v. Washing-
ton, 229 Kan. 47, 51, 662 P.2d 986, 990 (1981). The booklet cited by the court as contra-
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been established if this small amount of research was truly the
only information on the subject. The presentations in Washington
indicate that the evidence on EAP deterioration is minimal, but
contradictory. The fair conclusion from such scanty evidence
should be that although the defense has not proven the tests unre-
liable because of-the degradation of the dried blood, neither has
the prosecution established that the test is reliable. Instead, the
evidence indicates that reliability remains an open question.
Since the question of reliability was not resolved by the evi-
dence, the party who had the burden of proof on that issue should
lose. The defendant lost, and therefore, he must have had that
burden. The reason the burden was placed on him is the same as
in the other cases-because many forensic labs use the tests. As
the court acknowledged, "We are impressed by the testimony that
the Multi-System analysis is reliable and generally accepted in the
scientific field as illustrated by its present use in over 100 criminal
laboratories in this country and that the FBI research laboratory
uses the Multi-System analysis routinely and approves it."' 2
In Washington, as in Robinson and Young, once the prosecution
presented evidence that the tests are widely used by the law en-
forcement laboratories, "2 the burden shifted to the defendant to
dicting Grunbaum, which also was published as an article in the Journal of Forensic Sci-
ence, was written by employees of the Aerospace Corporation. See Denault Study, supra
note 32, at 479. Since no independent study by Stolorow has been found on the disputed
point, it is not unreasonable to assume that he was relying on this other Aerospace research
in giving his opinion. If so, it was not two pieces of evidence contradicting Grunbaum that
were given, but rather only one piece under two different guises.
12 229 Kan. at 55, 622 P.2d at 992.
122 The defendant raised an issue about the field of forensic science. The court charac-
terized the argument in the following manner: "The defendant futher suggests that there is
a difference between the field of forensic science and the field of biochemistry, which ren-
ders a forensic expert incompetent to testify on the reliability of blood analysis tests, in
contradiction of the testimony of a biochemist." 229 Kan. at 55-56, 622 P.2d at 993. This
argument apparently contended that forensic scientists do not have the training, qualifica-
tions, and experience to make judgments about reliability. The court rejected this
contention:
The area of forensic science is obviously made up of many different types of ex-
perts, as evidenced by Stolorow's qualifications in chemistry and forensic chemis-
try. Stolorow, as a forensic chemist, and Dr. Grunbaum, as a biochemist, both
specialize in microanalysis and serology. Defendant's position that the only ac-
ceptance of the Multi-System analysis is among law enforcement officers un-
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show that the genetic markers tests in dried blood were unreliable.
Even though the defendant produced evidence of unreliability,
that evidence was inconclusive. Therefore, the defendant did not
meet the burden implicitly placed on him by the court, and the
evidence was admitted.
B. The Proper Burden of Proof
The courts uniformly have indicated that the dried blood genetic
marker tests are admissible unless the defendant carries the bur-
den of showing that the tests are unreliable.12 3 This approach is
improper. Evidence is probative only if it is trustworthy. As one
commentator observed, "For evidence to contribute to the truth-
determining function of a trial, it must be reliable."12 This maxim
is equally applicable to scientific procedures: "The probative value
of scientific evidence, however, is connected inextricably to its reli-
ability; if the technique is not reliable, evidence derived from the
technique is not relevant. 1 25 Reliability of the dried blood genetic
trained in the chemical analysis of blood and other body fluids, is not supported
by the testimony, and we find this argument to be without merit.
Id. at 56, 622 P.2d at 993. This last sentence is not clear. The court could be stating that
acceptance of this technique is not limited to law enforcement officers. Such a conclusion is
not supported by the rest of the opinion, which indicates that the test is only used in foren-
sic labs. More likely, the court's sentence is rejecting the contention that the law enforce-
ment officers are incompetent to do genetic marker analyses. Of course, even if some foren-
sic scientists have qualifications as acceptable as Stolorow's, that does not mean that people
performing the test at all one hundred labs do. More important, however, is that the court
never recognized the crucial importance of the fact that this technique is confined to foren-
sic work; that is, even if done by competent people, the results are not used in any way that
shows whether or not those results are reliable.
'" Some approaches to scientific evidence that view the Frye staudard as too stringent
suggest that traditional evidentiary rules of relevancy should apply. See Giannelli, supra
note 42, at 1232-45. Even if this were the approach adopted by a court presented with the
introduction of the forensic genetic marker tests, the same considerations analyzed here
would control because, "in effect, the relevancy approach places the burden on the party
opposing admissibility.. . . Instead of the prosecution carrying a substantial burden of es-
tablishing the reliability of a novel scientific technique, the defendant must shoulder the
burden of establishing unreliability." Id. at 1246.
224 Id. at 1200.
"15 Id. at 1235. See also United States v. Brown, 557 F.2d 541 (6th Cir. 1977), in which
the court equated the Frye standard "with a showing that the scientific principles and pro-
cedures on which expert testimony is based are reliable and sufficiently accurate." Id. at
556.
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marker tests should be the key concern in determining their ad-
missibility. The only way the reliability of the dried blood tech-
niques can be established is through thorough validation studies.
Just as universal use of the paraffin tests did not assure reliability,
it should be apparent that widespread use of the dried blood tests
is no guarantor of dependability.
Since use by forensic scientists does not guarantee reliability, the
only way anyone can determine if the tests work is if controlled
experiments are conducted seeking to verify reliability under the
conditions that will be met in actual casework. It might be argued
that this has already been done. A scientist, for instance, may de-
velop a procedure that detects and groups a polymorphic genetic
marker. He then may modify this technique to use it on blood
which he has dried overnight on a swatch of cotton sheeting. After
repeating his work many times, he may announce that he can de-
tect this genetic marker in dried blood. Does this establish the reli-
ability of his procedure? Perhaps, but only for blood dried on a
cotton sheet overnight under laboratory conditions. It does not es-
tablish that the technique is reliable for blood dried for one week,
or two weeks, or months. It does not establish that the test works
for blood dried on denim, or leather, or polyester. It does not show
that it is reliable for blood dried at high humidity, or perhaps very
low humidity, or at high or low temperatures. Perhaps it matters if
the blood dried under intense light or no light; perhaps it matters
if the cloth was contaminated with substances in addition to the
blood. Such conditions all could be encountered in bloodstains im-
portant to a criminal case. More important, no one may-ever know
under what conditions blood taken from such a place as the defen-
dant's clothes has aged and dried.126 Only when experiments have
been done exploring the many permutations of these possible aging
conditions can the analysis of the bloodstain in a criminal case be
certified as reliable.
Also, it is important to ascertain not merely whether the genetic
marker can still be detected after being dried in a certain manner,
12 See A. MOENNSENS & F. INSAU, supra note 10, at § 6.12 ("Exact determination of
blood age is impossible.").
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but whether the reading of the detected group has changed. This
requires experiments that first reliably separate the fresh blood
samples into groups according to different genetic markers, and
then determine that subsequent readings taken at various stages of
drying show the same genetic markers in the separate groups.
Thus, the mere conclusion that the genetic marker was always
found in blood dried for ten days is meaningless. Not only must it
be found, it must be found in the same group as it was originally
detected. If for some reason after drying, the blood group the ge-
netic marker is found in appears to be different from the one in
which it was originally found, then the test is unreliable.
If the burden of proving reliability is on the defendant, he would
have to present the results of the verification experiments to the
court. If sufficient studies did not exist, he would have to have
them done or lose on this issue. Of course, it is not likely that a
defendant could carry such a burden. Such scientific scrutiny takes
a continuing commitment of time and money from trained experts.
Laboratories and equipment are necessary. Time is needed to pub-
lish the results and disseminate them so that other scientists can
analyze the methods, data, and conclusions as well as to see if the
work can be replicated. It is nonsensical to expect a defendant ei-
ther to perform such work or have it performed. For practical pur-
poses, all a defendant can do to prove unreliability is to survey the
published literature to see what verification studies have been
done. If those studies are deemed insufficient or inconclusive by
the court, the defendant will be unable to meet his burden. If the
existing research has not been thorough, the disputed tests may be
unreliable. Even so, the procedures would still be admitted.127
27' For the same reason, the evidence should not be admitted with questions about reli-
ability left to the jurors in their assessment of the weight to be given to the scientific proce-
dure. This would presuppose an adversary system in which each side can bring all the infor-
mation before the jury. Here, however, the defendant is at the mercy of the existing
scientific literature. Even if the tests are unreliable, he will not be able to present that
evidence to the jurors unless the appropriate studies have already been published. If the
research has not yet been done, the defendant has no way of producing evidence of unrelia-
bility. Thus, the material for a determination about dependability cannot be brought before
the jury and, consequently, that body cannot be expected to give accurate weight to the
scientific evidence.
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Instead, since reliability of the dried blood genetic marker tests
should be the concern of the court, the court must place the bur-
den of proving reliability upon the prosecution. If there are insuffi-
cient studies now, change will occur only when the prosecution has
the incentive to do more. Only the prosecution, through its forensic
labs and its ability to fund research, can assure the continuing
commitments that valid work is done. Law enforcers, of course,
have a stake in having the genetic marker tests admitted into
court, but the current legal situation is such that they can get them
admitted without having to establish reliability. Therefore, the re-
search to establish reliability is at present an unnecessary waste of
time and money for the forensic laboratories. The only way prose-
cutors will have the incentive to do the verification experiments
and the only way to assure that reliable evidence is being intro-
duced at criminal trials is for the courts to insist that the prosecu-
tion do more than merely present evidence that the dried blood
genetic marker tests are used in many forensic labs. Instead, the
courts must also impose upon the prosecution the burden of estab-
lishing that the tests are actually reliable.
IV. THE RELIABILITY OF GENETIC MARKER TESTING
The crucial concern for admitting the new blood procedures into
criminal cases should be whether they have been proven reliable. A
survey of the scientific literature indicates, however, that science
has done little to verify the reliability of the tests. Instead, the
scientists have concentrated primarily on perfecting the techniques
to identify the markers with little concern shown for proving the
reliability of these techniques under practical conditions. Con-
versely, as this portion of the paper will show, the little research
which has been conducted regarding the reliability issue indicates
not only that the tests have not been proven reliable, but also that
the research has repeatedly demonstrated that genetic marker
tests are unreliable.
The research concerning the detection of genetic markers in
dried blood contains few comprehensive studies on how various ag-
ing factors affect the genetic markers. Instead, the researchers have
concentrated on making the tests practical. Genetic marker testing
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in dried blood will be of little value to law enforcement if the pro-
cedures are cumbersome, complex, and can only be done by highly
trained scientists, because police laboratories are often staffed pri-
marily by technicians. A major goal of the research thus has been
the "[d]evelopment of a simple, rapid, reliable and economical
technology for blood and bloodstain analysis for forensic
uses. .... "128 Almost all of the research has concerned the im-
provement of measuring techniques. Noting the lack of compre-
hensive research, one author, who has surveyed the literature on
the detection of genetic markers in dried blood, has observed that,
"Forensic serological research has indeed been limited, and it has
been concerned primarily with methodology development. '12
228 Grunbaum, Foreword to HANDBOOK FOR FORENSIC INDMDUALIZATION OF HUMAN
BLOOD AND BLOODSTAINS V (B. Grunbaum ed. 1981). Other objectives were also set to make
genetic marker testing practical for the forensic scientist. Some listed goals of Grunbaum's
work were the "establishment of reliable data on a number of genetic markers in human
blood, on a statistically valid sample representative of the four major ethnic groups in the
California population," and "[t]he communication of project accomplishment from the aca-
demic research laboratory so that the information may be put to practical use for the bene-
fit of civil and criminal justice." Id. Valid studies of the frequency with which genetic mark-
ers appear is essential for forensic purposes. "The usefulness of these determinations in the
criminal justice system is dependent upon a knowledge of the frequency of occurrence of
these genetic factors in a general population or in a specified subpopulation." Grunbaum,
supra note 2, at 3. It would mean little if the genetic markers in a bloodstain matched a
defendant's or crime victim's blood if half the population had those same markers. See
supra note 20, for an illustration of what might happen if 50% of the population had the
same typing as the defendant. The forensic scientist, consequently, must know how fre-
quently particular markers appear in the population. Similarly, the research has little prac-
tical value unless it is successfully disseminated to the practicing forensic serologists. The
goal of this research is to do the work necessary so that genetic marker testing can go into
effect in the police laboratories. Nowhere, however, is the goal of comprehensively checking
reliability under all practical conditions mentioned.
"' Zajac, supra note 17, at 160. It does not follow that just because most of the re-
search has concerned methodology that the methods are now foolproof. The resulting prod-
uct of electrophoresis is not objective, but rather one that requires interpretation. There-
fore, "the degree of skill and information of the analyst who 'reads' the pattern on the
electrophoretogram" is important. Grunbaum, supra note 37, at 54. Grunbaum has con-
cluded: "As a safeguard against possible error, it is advisable for determinations on a single
sample to be made by two analysts working independently. If that is not possible, indepen-
dent readings of all electrophoretogramns by two analysts may serve to confirm the read-
ings." Id. at 103. See also Denault Study, supra note 32, at 493. The authors therein stated
that. "In the actual practice of serological evidence analysis, however, the importance of
conducting tests at least in duplicate and sometimes in triplicate, and with proper controls,
cannot be overemphasized." Id. Grunbaum has also stated that even though improved
methodology has eliminated many problems, "blood analysis will never be an error-free
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The production of apparently workable techniques, however, is
only the first step towards reliability. Once techniques are per-
fected, controlled experiments seeking to verify dependability
must be performed. These experiments should test the procedure's
limitations and search to find out when, if ever, the methods seem
to work but in fact give wrong results. Since the forensic genetic
marker tests will not be used in a way that will reveal any errors,
such studies will be the only way to verify reliability. If reliability
is to be proven, this research ought to be especially thorough and
comprehensive. Unfortunately, almost no such research has been
done.
A. Persistence Research; Warning Signals About Reliability
Once the methodology was developed so that it became practical
for law enforcement use, research virtually ceased. However, al-
though not designed to probe directly the areas of potential unreli-
ability, some off-shoots of the methodology research have bearing
on the issue. For example, after some genetic markers were discov-
ered in dried blood, follow-up work was done to discover how long
the markers persist in the bloodstains. This information is impor-
tant to the practicing forensic serologist who will not want to
spend the time, effort, and money doing tests if it is certain that he
will not get meaningful results. One such study noted that, "The
purpose of this detectability study is to provide the practicing
criminalist with adequate data to permit the selection of those
blood genetic marker systems for serological analysis that have a
high probability of yielding significant results."'130
Persistence research, however, has produced conflicting conclu-
sions. A 1980 review of the scientific literature stated that:
"Detectability of antigens and enzymes in dried blood ranges from
a few days to years, depending on the conditions of specimen expo-
sure and on the particular genetic marker system being tested.
Even for a single system there is little agreement among investiga-
tors on time limits for variant detectability."'' These researchers
'cookbook' technology." Grunbaum, supra note 37, at 52.
130 Denault Study, supra note 32, at 479.
13, Id. at 480.
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also noted that the current investigation was initiated "because of
the large discrepancies in available data and because of the paucity
of information on the effects of materials and humidity on the sur-
vival of genetic markers in bloodstains."' 2 They further concluded
that, "This is one of the few comprehensive detectability studies
that takes into account, for a large number of genetic marker sys-
tems, the factors of bloodstain history, that is, the material on
which the blood was deposited and the humidity at which it was
stored."""3
Despite efforts to make their study detailed, however, these
scientists recognized that their data was extremely limited and
that most of the research in this area has yet to be done:
The information in this report will be useful to the forensic
serologist, who must decide for each bloodstain problem the
genetic markers to test. However, emphasis must be placed on
the limitations of this study. It is intended as a starting
point for future research. It covers a limited number of ge-
netic markers and marker systems, aging conditions, analyti-
cal techniques, and investigative skills. Moreover, the tests
were conducted on clean specimens free of impurities. It is
realized that in actual practice serological evidence preserved
under known and constant conditions is rare, and the speci-
mens may be contaminated with impurities such as perspira-
tion, urine, soil, and bacteria. These factors limit the applica-
tion of the results of the study."'
In spite of this declaration, once funding for this specific study
stopped, these scientists discontinued their research in this area.13 5
Furthermore, the scientific literature does not indicate that anyone
132 Id.
133 Id. at 479-80.
13 Id. at 496 (emphasis added).
135 In a letter dated July 21, 1981, from Genevieve Denault to this author, Denault
stated that the study had been done under contract to the Law Enforcement Assistance
Administration (LEAA). When that contract ended, the scientists shifted their research to
areas concerning the Air Force, including propellant stability and radiation effects in space.
The LEAA funding for the genetic marker research was consistent with its practices in other
areas by not funding verification studies. As Giannelli has concluded: "The LEAA can be
criticized for failing to establish such an evaluative process as part of its procedures." Gian-
nelli, supra note 42, at 1232.
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else is conducting similar comprehensive research into the persis-
tence of genetic markers in dried blood.
As limited as it has been, persistence research is crucial because
it contains the seeds of reliability studies. Of course, the trustwor-
thiness of the evidence presented in court does not depend on how
long a scientist can detect a genetic marker in dried blood. If after
a certain time the scientist gets no reading, then no evidence would
be presented at a trial. Instead, reliability depends not only on
whether a phenotype can be detected in the bloodstain, but also on
whether the phenotype reading in the stain is the same as that
found in fresh blood from the same person. Reliability is not estab-
lished from the mere fact that a genetic marker system can be de-
tected in aged blood; instead, the crucial question is whether the.
marker detected in aged blood is a reliable indication of that found
in fresh blood from the same person.
The limited data available on this issue is startling and dis-
turbing. As the following discussion will show, research has estab-
lished that the forensic serologist testing aged blood will be able to
"read" the genetic markers in a sample, but the readings may be
different from those in fresh blood because of changes in the blood.
In other words, the blood typing will be wrong. Not only will it be
wrong, but the forensic serologist will have no way of knowing that
a "false positive" has occurred. To date, almost nothing is known
about why, when, or how often such alterations occur.
Blood changes quickly outside the body. "Blood, as an extremely
perishable biological substance, alters from the moment that it
leaves the body, or, if drawn from a cadaver, from the moment of
death. The alteration may be fast or slow, depending on environ-
mental conditions and possible exposure to chemical contamina-
tion."13 The changes can be of different sorts. Sometimes the de-
terioration of the blood means that no genetic markers are
observed; however, "[tientative experimentation has indicated that
136 Grunbaum, supra note 2, at 2. See also BLOOD GROUP, supra note 11, at 408;
Denault Study, supra note 32, at 494; Rothwell, The Effect of Storage upon the Activity of
Phophoglucomotase and Adenylate Kinase Enzymes in Blood Samples and Bloodstains, 10
MED. ScI. & L. 230 (1970); Zajac, supra note 17, at 1605.
1982] 879
EMORY LAW JOURNAL
these markers may change in a manner which may give false read-
ings rather than no reading at all. '137 Thus, reliability is not
proven by experiments that indicate a genetic marker is present in
dried blood.
While experiments with laboratory-prepared bloodstains indi-
cate that blood group factors persist in aged samples, there is
no guarantee that these markers will remain unchanged in ev-
idential material. Phenotypes in some contaminated, dried, or
putrified blood may be in an altered and degraded state
which gives an unambiguous but false reading.138
Laboratory work is of limited value because it has seldom ap-
proached field conditions:
Most of the experimental work has been done using dried
bloodstains prepared in the laboratory under "ideal" condi-
tions and with blood samples which usually contain an antico-
agulant and/or preservative. Consequently, numerous reports
cite "no problems" or "no mistypings" in "blind trials". How-
ever, recent publications are reporting definite alterations in
apparent phenotypes in bloodstains and degraded samples for
some of the enzyme and protein systems.139
No technique now exists to change the unambiguous, but false
reading to the correct one, and no reason exists to believe that
such procedures will ever be developed: "To date, we have no evi-
dence that these changes can be reversed. Improvements and
changes in electrophoretic methodology will be to no avail if the
determiner enzyme/protein has altered through aging and
deterioration.140
W Zajac, supra note 17, at 160. See also BLOOD GROUP, supra note 11, at 408; B. CuL-
LIFORD, supra note 3, at 142.
131 Zajac, supra note 17, at 163 (emphasis added).
139 Id. at 167.
140 Grunbaum, supra note 37, at 103 (emphasis in original). Although an analogy
between fingerprints and genetic mbrkers may sound appealing, the differences in the
detectability of any alterations constitute an important reason why the comparison fails.
"After a fingerprint or partial print has been found and photographed, the expert can be
quite certain of what he has to work with and he may proceed with an individualization
based on visual examination of morphological details. If the fingerprint pattern is in any
way physically altered prior to photographing, this alteration is apparent." Grunbaum,
supra note 2, at 2.
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So far, scientists have hardly studied this crucial area of the
false positives.141 Not surprisingly, therefore, "to date little is
known regarding many of the enzyme/protein systems in terms of
stability, degradation, and reliability of phenotyping stains and
samples of questionable history. ' 142 The safest conclusion is that
much research is still needed, 43 but it can now also be concluded
that genetic markers sometimes change because "proteins and en-
zymes degrade in unpredictable ways." 44
A closer look at the scientific findings is in order. It will be espe-
cially instructive first to examine the evidence about the reliability
of the detection by forensic scientists of the ABO groups and other
antigens. The antigen procedures have existed longer than the
electrophoretic ones. Consequently, the reliability of the antigen
procedures have been more fully explored than the reliability of
the newer tests. It is especially disturbing, then, to find out how
little is actually known about the typing of antigens in dried blood.
B. Reliability of ABO Typing in Dried Blood
The reliability of ABO detection in bloodstains seems certain to
forensic scientists. One scientist reports that, "The ABO system
appears to be more persistent and stable than other antigen, en-
zyme or protein systems, and the procedures are more simple and
straightforward than for the other antigens."'45 The group that has
made the most thorough study of how aging conditions affect the
persistence of genetic markers concludes that, "The evidence im-
plies no significant substratum, humidity, or temperature effects
on the persistence of ABO antigens, at least up to 26 weeks." 4
141 See Zajac, supra note 17, at 160.
142 Id. at 167.
143 See Baxter, supra note 2, at 292.
144 Grunbaum, supra note 37, at 103.
145 Zajac, supra note 17, at 164. See also BLOOD GROUP, supra note 11, at 408.
14' Denault Study, supra note 32, at 485. The substratum means the material upon
which the blood dried. In the Denault study, those materials were "glass, wool, nylon, and
three types of cotton (plain cotton, permanent press, and denim)." Id. at 480. Other scien-
tists "have reported A and B antigens to be detectable on bloodstained fabric at ambient
conditions after two years. They also successfully typed a 34-year-old Type A stain. Their
analyses were also conducted with the absorption-elution method on stains prepared on dif-
ferent fabrics substrata that included cotton, wool, silk, and synthetic materials such as
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Thus, one of the pioneers in the study of phenotyping in dried
blood has concluded that, "In experienced hands, the grouping of
dried bloodstains in this [ABO] system presents relatively few
problems. 14 7
As we shall see, however, even ABO detection is beset with pit-
falls. For one thing, trained personnel working carefully are essen-
tial.148 Careless laboratory work can lead to wrong ABO groupings
in bloodstains-that is, to false positives. For instance, "too large a
sample or thread for antigen determination increases the chances
of nonspecific absorption of antiserum and subsequent insufficient
washing of the unabsorbed antisera. The consequence is a false
positive reaction.' 4 9 Wrong groupings may also result from the an-
tiserum. "Antiserum that is too concentrated may produce aggluti-
nation in negative controls, and antiserum that is too dilute may
result in insufficient absorption and subsequent false negatives.' 150
The forensic serologist "must run casework stains in duplicate
under rigidly controlled conditions with appropriate standards and
controls."'15'
False ABO positives, however, are perhaps most often caused by
contaminations from other secretions. The ABO antigens appear
not only in blood, but also in other body fluids in most people:
nylon and rayon." Id. at 485 (summarizing Fiori, Marigo, & Benciolini, Modified Absorption
Elution Method of Siracusa for ABO and MN Grouping of Bloodstains, 8 J. FORENSIC SCI.
419 (1963)).
117 B. CULLIFORD, supra note 3, at 75.
" These caveats also apply to the grouping of fresh blood:
The fact that blood typing has been routinely performed in the armed forces and
in blood banks has led to a misconception as to the ease with which such tests
may be made. It has been estimated that approximately 10% of the ABO group-
ings entered on the "dogtags" of World War II servicemen were erroneous. Only
specially trained technicians are qualified to carry out blood tests that can be re-
lied on.
2 AM JUR. PROOF OF FACTS, Blood Types 608 (1959). It is reported, however, that "errors in
blood grouping today are rare, and when they do occur, can invariably be related to a cleri-
cal error, an error in identification rather than to an error in grouping at the laboratory
bench." Baird, supra note 1, at 89.
149 Zajac, supra note 17, at 165.
Denault Study, supra note 32, at 481. Zajac similarly reports that "false positive
reactions may result with the absorption-elution procedure when an antiserum of too high a
titer is used." Zajac, supra note 17, at 165.
191 Zajac, supra note 17, at 165.
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Approximately 80-85% of the population, known as secretors,
have blood group substances in their saliva, tears, perspira-
tion, semen, vaginal fluids, mucus, gastric contents, etc. The
quantity of blood group antigen in semen and saliva, for ex-
ample, is much greater than that found in red blood
cells.... The remaining portion of the population do not se-
crete these blood group substances.'5 2
Mistyping of the blood can occur if an apparent bloodstain is
actually a mixed stain of dried blood and another fluid from a se-
cretor. 153 In one study, for example, urine and perspiration from a
secretor of the B type was put over bloodstains of different groups.
The subsequent analyses discovered that
both urine and perspiration from a known type B secretor
caused [the] three type 0 donors to react as though these
bloods were type B. The effect of the urine was more pro-
nounced than the effect of perspiration. With type A donors
the effect of B secretor urine was to give an absorption effect
as would be obtained with an AB stain. With both known AB
stains there was no observable effect of either contami-
nation.'"
The scientific investigators concluded that, "The effect of contami-
nation from body secretions of a secretor donor was exactly the
same as if his blood were added to the stain. . . .[Sluch contami-
nation by secretor fluids can produce serious error in absorption
tests."155 They concluded that special care must be given in report-
"' A. MO.NSSENS & F. INBAu, supra note 10, at § 6.11. See also B. CULLIFORD, supra
note 3, at 98. Culliford states that: "Classification into secretor and non-secretor is usually a
very simple matter, but occasionally it is difficult to assess. There is also evidence that some
individuals secrete in one body fluid and not another." Id. In addition, he warns, a small
percentage of people show a different group in their secretions than in their blood. Id.
M See BLOOD GRouP, supra note 11, at 410. "False conclusions may be reached if the
possibility of a mixture is not realized." Id. See also B. CULLIFORD, supra note 3, at 75;
Baxter, supra note 2, at 295; Zajac, supra note 17, at 164-65.
14 Marsters & Schlein, Factors Affecting the Deterioration of Dried Bloodstains, 3 J.
FORENSIC Sci. 288, 297-98 (1958). In another study, type A bloodstains were contaminated
with type B sweat and type B bloodstains were contaminated with type A sweat. The subse-
quent grouping found both type A and type B in most of the stains. See Aye, The Reliabil-
ity of ABO Grouping of Bloodstains Contaminated with Sweat, 18 J. FORENSIC SCI. Soc'Y
193 (1978).
"I" Marsters & Schlein, supra note 154, at 299.
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ing a bloodstain as type AB, the rarest of the ABO groups,156 for it
might be the combination of blood and some other fluid. 157
Because of the possibility of such contamination, "the necessity
for adequate controls from an unstained portion of the item cannot
be over-emphasized. These should be taken from as near as possi-
ble to the bloodstain." L58
Usually, a washing stage is incorporated in this method. Be-
cause stains are ordinarily encountered on fabric, it is neces-
sary to test unstained material in order to establish the pres-
ence or absence of contaminants and to determine whether
the washing has been complete. 159
If the control samples show no antigenic activity or only a weak
reaction, the serologist may be able safely to type the stain. If the
control samples show a strong reaction, however, the typing of the
bloodstain should not be considered reliable."' ° Consequently,
ABO groupings of bloodstains not done in conjunction with suita-
ble controls should be considered untrustworthy.
I" See A. MOENSSENS & F. INSAU, supra note 10, at § 6.11 ("Roughly 40 percent of the
population in the United States is type A, 43 percent is type 0, 14 percent is type B and 3
percent is type AB."). Id.
'17 A report of type AB blood in a stain may also be considered suspect for another
reason:
[T]here is difficulty in the interpretation of negative results. Such negative read-
ings may indeed mean that the particular factor was never present in the blood,
but negative results may also be caused by denaturation of the bloodstain, deteri-
oration or masking of the reaction, or insufficient antigen. Consequently, the fo-
rensic analyst working with aged or dried blood specimens should regard only pos-
itive results as significant.
Zajac, supra note 17, at 166. This must be considered if the "Lattes method" is used to type
the dried blood:
The disadvantage of the method is that the agglutinins, ie. [sic], the antibodies,
are not stable. They are very quickly altered or denatured in dried stains and no
longer react. Also a group AB bloodstain does not contain anti-A or anti-B antibo-
dies and hence when group A or B indicator red cells bearing the antigens are
brought into contact, no reaction, ie [sic], agglutination, will take place. It is dan-
gerous to report the group of a bloodstain, however fresh, based on negative
findings.
Baird, supra note 1, at 101.
I" B. CULLIFORD, supra note 3, at 75.
159 Baxter, supra note 2, at 294.
160 See Aye, supra note 154, at 195.
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According to at least one forensic serologist, controls are also
necessary because of possible contamination from sources other
than body secretions:
False positive ABO antigen reactions can also result from
contamination with such substances as molds, bacteria,
household dusts, detergents, and the decomposition of the
samples, and from such substrates as leather. The effects of
such substances on a bloodstain are unpredictable. Loss, ad-
dition and substitution of antigenic activity upon decomposi-
tion of the sample have been observed and reported .... It is
essential to run unstained portions of the substrate, taken
near a bloodstained area, and to use the Lattes test in con-
junction with the absorption-elution tests for confirmation of
the ABO phenotypes. '
This passage should be considered carefully. If the role of the legal
system is to be more than just a passive recipient of the scientist's
assertions, questions certainly should be asked at this point. First,
conditions that can produce false results are noted. Then it is
stated that it is crucial to run control samples and to run various
tests. However, how will these steps cure or prevent the problems?
Nothing indicates that the ABO antigens are contained in molds,
bacteria, household dusts, detergents, or leather. If those sub-
stances sometimes do produce false positives as the scientific liter-
ature states, it is not because, like the secretions, they are adding
their own antigens to the dried blood. Instead, it seems plausible
that these contaminants produce erroneous readings because they
actually change the antigenic activity of the blood. If that is the
case, it is hard to see how running a control on a piece of fabric
without the stain will show that the dried blood elsewhere on the
fabric has changed. Since the effects of these contaminants are
"unpredictable," and since no reason is presented to believe that
the wrong results can be detected, how then are we to know if the
ABO typing of dried blood is correct?
161 Zajac, supra note 17, at 165. Concerning the same area, Culliford merely delivers
this cryptic comment without further elucidation: "The possibility of obtaining false posi-
tive [ABO] reactions caused by bacterial contamination cannot be ignored but, in practice,
this is not a problem." B. CULLIFORD, supra note 3, at 75.
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Furthermore, why should the control detect the "addition and
substitution of antigen activity upon decomposition" of the blood?
Although the Zajac passage quoted above indicates that decom-
posed blood can lead to false ABO typing, it does not suggest any
way to detect or prevent that change. Since blood starts decompos-
ing the moment it is shed,"6 2 does the quoted statement indicate
that the typing of all ABO stains is potentially unreliable? Do we
know what aging conditions bring on these false positives or how
often the wrong results occur? Zajac offers her observations that
contamination can produce wrong readings and that decomposition
has been observed to produce substitutions without explanation.
These are crucial questions, but no answers are given.
One major study indicates that far from being idle concerns,
these issues should be considered important by both forensic scien-
tists and lawyers. In Detectability of Selected Genetic Markers in
Dried Blood on Aging (Denault Study),6 3 the authors tested the
detectability of several genetic markers, including the ABO system,
by depositing blood on six kinds of material, aging some of the
resultant samples at room temperature of 230 C. and sixty-six per-
cent humidity, and a few at -20° C. Examinations of the stains
were then made at four, thirteen, and twenty-six weeks. The scien-
tists concluded that "the evidence implies no significant substra-
tum, humidity, or temperature effects on the persistence of the
ABO antigens, at least up to 26 weeks.1164 A close look at their
data, however, once again raises questions.
First, the data is very limited. Can authoritative conclusions be
drawn from the few samples tested? Through thirteen weeks,
twenty room-temperature-dried specimens were examined for the
ABO antigens. Are a score of samples truly sufficient to prove reli-
ability? If each permutation of the tested conditions is considered
separately, the numbers are miniscule. For example, only two ny-
lon samples dried at sixty-six percent humidity were tested. Does
162 See supra text accompanying notes 135-36 for a discussion of the effect of deteriora-
tion on the reliability of dried blood testing.
103 Denault Study, supra note 32. See supra note 146 for a discussion of the materials
used in the Denault Study.
I" Denault Study, supra note 32, at 485.
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the conclusion that no problems were found in those two tests es-
tablish that no problems will be found in one hundred or more
samples? Even if the conclusions about the tested conditions can
be correctly drawn from the limited data, do the same conclusions
apply to nontested situations? Are ABO antigens reliably detected
in a stain found on a sneaker, for example? 1 5
Consider another situation. Suppose a women is stabbed to
death and two weeks later a man is arrested. A bloodstain is found
on his workshirt, and analysis reveals it is type A blood. The vic-
tim had type A, while the defendant has type B. The defendant
states, however, that the stain was acquired several months ago
when he cut himself on a construction job. Since then he has worn
the shirt nearly daily and laundered it periodically. If he is telling
the truth, the stain has aged part of almost every day at the tem-
perature of his working body; it has been repeatedly soaked with
perspiration and dirt;166 it has been dried at room temperature at
night; and it has been subjected several times to household deter-
gents.167 If the stain had been subjected to these not far-fetched
conditions, does the data of this study truly indicate anything
about whether the typing of it would be without error?
A closer look at this data indicates not only its limited nature,
but also that the scientists' conclusions are not always supported
by their own reported results. At twenty-six weeks, eighteen sam-
ples dried at room temperature were examined for ABO anti-
gens.168 The investigators reported false positives in four of these
samples,16 9 meaning that they "found" an antigen which was the
,65 See State v. Fulton, 299 N.C. 491, 263 S.E.2d 608 (1980) (evidence crucial to case
was bloodstain found on tennis shoe).
166 One scientist knowledgeable about dried blood has concluded that heat and humid-
ity, especially in combination, adversely affect ABO detection. See Outteridge, The Biologi-
cal Individuality of Dried Bloodstains, 5 J. FORENSIC SCI. Soc'Y 22, 28-29 (1965). Several
scientists suggest that "the blood in general should be preserved in a dry environment. This
conclusion confirms the experience of criminalists, although no study attempting to verify
this has been reported." Denault Study, supra note 32, at 487.
167 See supra text accompanying notes 155-57 for a discussion of potential sources of
contamination of bloodstains.
163 See Denault Study, supra note 32, at 487, Figure 1.
169 Id. at 493, Table 6.
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wrong one more than twenty percent of the time.110 Since this
study was done under laboratory conditions, actual forensic sam-
ples could be expected to present more problems. 1 ' This could
mean that the twenty-two percent false positive rate is a lower
limit, with the actual rate of false blood group identification in
casework to be even higher.
And yet, the Denault Study concluded that they found no sub-
stratum effect on the ABO system. Of the eighteen samples tested
at twenty-six weeks, four were bloodstains on denim. Of those four
denim samples, three gave false positive readings. 17 2 As an expla-
nation for this seventy-five percent error rate, the authors stated
that, "Denim regularly unraveled upon being washed, and the at-
tempt to avoid this may have induced insufficient washing.' 73
This proposition was not tested, and no solution to prevent these
errors was proposed. This data, instead of proving that no
problems exist with the persistence of the ABO antigens up to
twenty-six weeks, actually indicates considerable unreliability at
that time. Clearly, the results show that the typing on denim at
twenty-six weeks lacks reliability.
Denim is hardly an unpopular fabric, and actual casework can be
expected frequently to encounter stains on it. Because these tests
have shown a problem with denim, one should expect to find fur-
ther research into this area. For example, the false positives were
first found at twenty-six weeks, not at four or thirteen. Does that
mean that the problem only occurs after three months, or were
earlier problems just missed because of the limited number of
denim samples (four)? Were the errors really caused by insufficient
washing (if so, why weren't false positives found on earlier tests
170 A different study reports proficiency testing that shows a 1.6% error rate for ABO
typing. The details of this testing, however, were not given, so these results cannot be com-
pared with the data produced by the authors of the Denault Study. See Shaler, Hagins, &
Mortimer, MN Determinations in Bloodstains-Selective Destruction of Cross-Reacting
Activity, 23 J. FORENSIC ScL 570 (1978) [hereinafter cited as MN Determinations].
171 See supra text accompanying note 133 for a discussion of the laboratory conditions
which limited the practical applicability of the Denault Study.
'72 The fourth was a bloodstain on nylon aged at 20% humidity. See Denault Study,
supra note 32, at 493.
173 Id. at 491.
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when the same washing problem also existed) or from some other
source? If from another source, would that cause also affect stains
on other materials? Even though this major study identifies what
appears to be a considerable problem with ABO testing, the subse-
quent literature shows no attempt to answer such questions raised
by the study.
Besides establishing an area of unreliability, this study should
also point out the dangers of drawing conclusions from limited
data. If the examinations had stopped at thirteen weeks, no false
positives in the ABO system would have been found. Although
three out of four denim samples showed false positives at twenty-
six weeks, if only one sample had been examined and it was that
fourth denim piece, no reason would have been presented to sus-
pect unreliable antigen reports for bloodstains on denim. It must
be stressed that this study is a major one which summarizes and
tries to build upon previous test results. Unfortunately, the study
has not been duplicated. If this is the last word on ABO detection
in dried blood, the genetic marker system that has been the most
used and studied, the research reveals not the stated conclusions of
its authors, but rather the paucity of information about the detec-
tion of those markers in bloodstains. Furthermore, the limited data
assembled has already uncovered areas in which false positives are
produced. Certainly it is fair to ask whether such scientific infor-
mation really proves that the tests are reliable.
C. Reliability and the Other Antigens
In 1965, one expert in the individualization of dried blood stated
that since the results were not reliable for other systems, "many
writers consider that the extension of bloodstain grouping outside
the major divisions of the ABO system would be a dangerous prac-
tice."' 174 Even today, the forensic scientist still often limits his
grouping of antigens to the ABO factors.
In the crime laboratory, bloodstain evidence is most fre-
quently typed for the ABO group system, and often there is
no determination of the other antigens.... Analysts are de-
O7 utteridge, supra note 166, at 40.
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terred from making antigen determinations other than ABO
for several reasons in addition to the cost or lack of time and
training. The determinations call for complicated and lengthy
procedures requiring numerous manipulations. A large
amount of sample is needed compared with the ABO and en-
zyme systems. Sensitive, specific, reliable and inexpensive an-
tisera for forensic use are not always available for the other
antigens. There is a necessity for rigid testing of all reagents
and strict quality control. The variability in antigenic concen-
trations causes problems with some systems."2 5
The antigen-antibody reaction in some systems is so slight that
their typing is inherently suspect. "The antigens of the Kidd,
Duffy, and Kell systems are extremely difficult to type because of
weak agglutination between the antigens and their antibodies. ' 170
Thus, these "agglutination tests involve a degree of subjective
judgment . .. [and] are prone to laboratory misclassification." 17
Not surprisingly, little scientific literature exists on the
detectability of these systems in dried blood.17
8
Several forensic serologists have suggested, however, that anti-
gen systems besides the ABO can be typed reliably under certain
circumstances. For instance, although "[t]he complexity of the
[Rh] system and its nomenclature was so great, that for many
years it was considered an unsuitable system for forensic pur-
poses, 179 noted British scientist Bryan Culliford has stated that,
176 Zajac, supra note 17, at 163-64. For discussions of the problems with antisera, see
Denault Study, supra note 32, at 483; Grunbaum, Selvin, Myhre, & Pace, Distribution of
Gene Frequencies and Discrimination Probabilities for 22 Human Blood Genetic Systems
in Four Racial Groups, 25 J. FoRENSIC Sci. 428, 439 (1980) [hereinafter cited as Gene Fre-
quencies]. About the forensic usefulness of these other antigen systems, Zajac concludes
that: "More reliable information can be obtained from smaller samples and with less time
and effort by utilizing several enzyme/protein systems in addition to the ABO system."
Zajac, supra note 17, at 167. See also Baxter, supra note 2, at 294-95.
17' Denault Study, supra note 32, at 487-88.
'7 Gene Frequencies, supra note 175, at 439.
7a See Denault Study, supra note 32, at 490.
17, Baird, supra, note 1, at 108-09. Baird indicates that it was not until the late 1960's
that a system for the grouping of the Rh factor in dried blood was first prepared and pub-
lished. Id. The intricacy of the Rh system could make it the most useful genetic marker for
the individualization of blood. "Because of the complexity of the Rh system, it is potentially
capable of providing results of greater significance than any other single red cell antigen
system or indeed any other form of blood typing with the possible exception of Gm." B.
[Vol. 31
WILL BLOOD TELL?
"With adequate recent bloodstains that have dried quickly, Rh
genotype is highly reliable."180 Even Culliford, however, goes on to
add caveats about RH typing:
With old stains or those of inadequate quantity, it is only safe
to draw conclusions from positive reactions. In these circum-
stances, one cannot be certain of the absence of an antigen
when a negative reaction is obtained. Stains that have dried
slowly present the greatest danger of erroneous typing and it
is never safe to rely on results from those smelling of putrified
blood.181
These limitations will, of course, often make the Rh system useless
in practice because the aging conditions will not fall within the
limited area in which Culliford finds high reliability, or because the
aging conditions will not be known.18 2 More important, however,
the scientist does not give any reasons why he has concluded that
Rh typing in dried blood is reliable even under restricted condi-
tions. No published studies have been found to support the naked
assertion. Instead, the literature details many problems with Rh
typing in bloodstains. 83 Even the limited research done by the
Denault Study found false positives using the Rh system, with the
majority of these occurring after only two weeks of aging at room
temperature."8 4
A scientist's assertion about the reliability of the detection of a
genetic marker in dried blood should not be accepted without ex-
perimental testing of such a conclusion. The need for reliability
testing is evident in the comments about the MN system, another
antigen marker, made by J. Brian Baird, a leading Canadian foren-
CULLIFORD, supra note 3, at 81.
Iso B. CULLIFORD, supra note 3, at 96. Baird likewise stated that: "Rhesus bloodstains
can be grouped, if they have been properly handled and air-dried at room temperature, for
periods of up to one month." Baird, supra note 1, at 109.
'Si B. CULLIFORD, supra note 3, at 96.
182 In ascertaining aging conditions to determine whether the Rh typing is reliable, Cul-
liford states that "[t]he appearance of the bloodstain to an experienced eye is a good guide
to the suitability for grouping. The behavior of the stain when tested for other components
is also a guide to its quality for Rh typing. For example, those which have lost PGM activity
are likely to give negative reactions in the Rh systems." Id. at 96-97.
:s For a summary of this literature, see Zajac, supra note 17, at 166.
,S4 See Denault Study, supra note 32, at 493, Table 6.
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sic serologist:
For forensic application, however, when one has to group
bloodstains the system poses several problems. The M and N
antigens are much less stable than the ABO antigens and if
the stains are more than several weeks old, grouping is likely
to be unsuccessful .... A further problem with the MN sys-
tem is that, if extreme caution is not exercised, a group M
stain can be erroneously grouped as MN. Controls must be
run at all times and the quality of the antisera must be con-
tinually monitored. In the hands of a competent and exper-
ienced serologist reliable results can be obtained on
bloodstains.1 85
Thus, even though problems exist, the right person can produce
valid MN results in dried blood. Baird, however, cites nothing to
support this final conclusion. After this statement, however, re-
search was done studying the accuracy of MN testing in forensic
laboratories. The data did not support Baird's earlier conclusion:
The results of the proficiency testing demonstrate that an er-
ror rate as high as 40% is obtained with MN as compared to
1.6% for ABO. These results suggest that the fault is not nec-
essarily in the ability of crime laboratory personnel to use
these techniques but quite possibly in the system itself or the
application of these particular techniques to the detection of
M and N antigens in dried stains. 86
Even more recently, Zajac, after reviewing the existing work, con-
cluded that:
At this time, the MN system must generally be considered
unsuitable to forensic work involving phenotyping of dried
bloodstains because of inherent unreliability .... The MN
system, because of its unreliability, probably should not be
determined in dried bloodstains until the problems inherent
18 Baird, supra note 1, at 108 (emphasis added).
MN Determinations, supra note 170, at 570. Culliford details problems encountered
with MN typing in dried blood, concluding that these problems "are inherent in the system
and a simple solution is unlikely." B. CULLIFORD, supra note 3, at 79. One of the major
sources of error is that the N antigen is often detected as the M and thus the M type may
be misgrouped MN. See also MN Determinations, supra note 170, at 570-71.
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to the system are identified and clarified.187
As the MN system illustrates, reliability of genetic marker detec-
tion in dried blood, even for antigens that were typed long before
the enzyme and protein systems, cannot be accepted on the basis
of a mere assertion, even that of a noted forensic serologist. In-
stead, reliability can only be established by reliability testing. Lit-
tle testing such as that done on ABO groups has occurred for the
other antigen systems. What tests have occurred either indicate, as
the limited Rh studies do, that reliability has not been established
and is suspect or, as with the MN system, that the tests in dried
blood are unreliable. The scientific literature produces similar con-
clusions about the detection of the enzyme and protein systems in
dried blood.
D. Reliability of the Electrophoretic Procedures in Dried Blood
-An Overview
Although the reliability of the tests for each genetic marker sys-
tem must eventually be considered separately, a review of the sci-
entific literature leads to some general conclusions about the mark-
ers detected by electrophoresis. First, almost no research has been
done on the reliability of the electrophoretic procedures using
dried blood. As with the antigen systems, what little can be
gleaned about reliability has come primarily from persistence stud-
ies. These studies all have notable limitations and do not prove the
reliability of the tests for any system.
For example, conclusions to be drawn from the electrophoretic
patterns are subjective rather than objective.188 Therefore, reliabil-
ity can only be verified with blind tests, and many persistence
studies have not employed even this elementary research tool. At a
minimum, blind testing requires that the researchers who do the
phenotyping in the dried blood be unaware of the samples' true
types. If the serologist knows what phenotypes he should find, his
eventual readings might be biased.
Some studies, aware of this potential problem, have withheld the
Zajac, supra note 17, at 166-67.
See Denault Study, supra note 32, at 485, 493.
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expected results from those doing the tests. If, however, the studies
are going to show that the procedures are reliable, the studies must
go further than just restricting advance knowledge of the specific
phenotype from the one analyzing the electrophoretic patterns.
The practicing forensic scientist not only should not know what
result he is looking for,' but also he will not know what aging
conditions the blood sample underwent before it was collected.
Even in the studies using blind testing, the serologist often knows
the circumstances under which the stain aged although he is una-
ware of the actual phenotype. Significantly, the little research that
has used readers ignorant of both the phenotypes present in the
stain and also of the aging conditions has reported many false
positives.190
The persistence studies likewise are deficient because they have
not studied stains under the myriad of conditions that real crimi-
nal evidence will have undergone, and thus these studies cannot
prove reliability in practice. For example, almost no work has been
done in such elementary areas as blood dried at body heat, stains
subjected to perspiration, blood dried on dirty clothing, stains aged
under temperature or humidity fluctuations, and all the possible
permutations of frequently encountered aging conditions.
Finally, the meager relevant research has highlighted some con-
ditions that could produce erroneous readings. Moreover, it has
produced reports of a high rate of false positives. Even with this
evidence pointing time and again to the potential unreliability of
the tests, these various results have almost never spawned the fur-
ther research that would seem necessary before any of the results
could be reasonably relied upon. A more detailed examination of
the research concerning specific genetic marker systems illustrates
189 Ideally, the practicing forensic serologist has no preconceived notion of what pheno-
types he is looking for. However, it is possible for bias to occur. In most criminal cases, three
readings are crucial-the dried blood, the blood obtained from the victim, and the blood
obtained from the defendant. If the same person does all three readings, he is not really
doing a blind test because he may expect that the stain will match one of the other two
samples. The better procedure, therefore, is for different serologists to make the readings on
each of the samples.
19 See infra text accompanying notes 239-41 for a discussion of the higher rate of false
positives that resulted when phenotyping was done completely blind.
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these points.191
1. PGM Testing
In 1978, Baird stated that, "Of the electrophoretic systems used
to characterize human bloodstains, the PGM system is probably
the most popular. ' 192 Phosphoglucomatase is typed more often
than any other enzyme or protein system. This wide use might lead
to the assumption that the reliability of PGM detection for foren-
sic purposes has been widely studied. The scientific literature,
however, indicates otherwise.
Though no reports of false PGM positives in bloodstains have
been found, only a handful of published studies have examined
how long PGM persists in dried blood, and that research has been
limited. 93 For example, one of the first studies used only PGM "2-
1" samples.194 This study noted that the phenotype of one genetic
marker may degrade differently from that of another phenotype of
the same marker. Since each of the different PGM phenotypes
seems to deteriorate differently in stored blood,195 it is questiona-
ble how much extrapolation can safely be done from one such
work.
The Denault Study, the most comprehensive study done on
PGM, is still quite limited. Only twenty-four samples dried at
room temperature were tested for PGM. With the various permu-
tations of drying conditions, this means that only one sample of
PGM "2-1" from a stain dried on denim at sixty-six percent hu-
midity was analyzed at thirteen weeks. 198 Because no false positive
191 No attempt has been made to discuss every system. More than twenty genetically
controlled polymorphic enzymes and proteins have been identified in bloodstains. See
Grunbaum, The Grunbaum System for Electrophoresis-Standardization of Equipment, in
HANDBOOK FOR FORENSIC INDxrDUALIZATION OF HuMAN BLOOD AND BLOODSTAINS 7, 33 (B.
Grunbaum ed. 1981). The systems which are discussed are those mentioned in the reported
cases; these systems are the ones most often used in routine case work. See Baird, supra
note 1, at 109.
112 Baird, supra note 1, at 112-13.
193 See Denault Study, supra note 32, at 496.
'" See RothweU, supra note 136, at 231.
195 Id.
199 See Denault Study, supra note 32, at 491, Figure 7.
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was found in this single examination, does it follow that false posi-
tives would never exist with such aging conditions?
197
A different study has presented evidence to show that false read-
ings occur with PGM typing. PGM deteriorates rapidly; the effects
are seen within a day after the blood is shed.19 This degradation
most often produces diffuse electrophoretic bands. 199 Furthermore,
although no false positives have yet been reported in bloodstains,
they have been reported in stored blood samples taken from
corpses, and in semen stains.
Thus, Zajac notes that "there has [sic] been reported alterations
of [PGM] electrophoretic patterns in post mortem samples
... ,00 Of course, it will often be crucial to know whether the
PGM typings change in blood taken from a dead person. In People
v. Carlson, °1 for example, the victim's body was found two days
after she was last reported alive. Blood was taken from the corpse
later on the day it was discovered. A bloodstain subsequently was
found on the defendant's jacket. A laboratory analyst testified at
trial "that the blood from the stain on Carlson's jacket possessed
ABO, PGM, and EAP characteristics identical to the victim's
blood .... ,01 Obviously, this evidence was truly damning to
Carlson only if the PGM phenotypes were typed accurately. 203 If,
however, the.PGM in the victim's body altered between the time
of her death and the laboratory tests, the stain may have indicated
nothing about the defendant's guilt.
If the PGM alters in the blood after death, then PGM analysis
may become worthless in homicide cases. Thus, it is crucial to
17 A conflict of opinion seems already to have arisen from the sparse study of persis-
tence concerning the effect of the substratum. The Denault Study indicates that permanent
press and denim fabrics hinder the detection of certain PGM phenotypes. Id. at 494. Cul-
liford indicates no effect from textiles except from the difficulty of handling thin materials.
See B. CULLIFORD, supra note 3, at 120.
198 See Rothwell, supra note 136, at 231, 233.
9 See B. CuLLwoRD, supra note 3, at 119.
Zajac, supra note 17, at 168.
201 267 N.W.2d 170 (Minn. 1978).
202 Id. at 172.
203 The evidence was truly damning only if the stain did not match the defendant's
blood. The opinion is silent on this point.
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know whether such alteration actually takes place, and if it does,
under what conditions. The needed research has not followed,
however. In spite of a report that such changes occur, no published
study has explored this critical area.'"
A published paper, however, indicates that storing blood can
produce false PGM positives.20 5 Ten samples of blood were stored
at room temperature and analyzed periodically. On day fifty-one,
no readings were obtained from two of those samples, five were
accurately typed, and the three remaining gave false results. Two
samples of PGM "2-1" were typed as "2" and one sample of PGM
"1" became "2-1." The authors concluded by suggesting that in
blood stored beyond five weeks, PGM should be interpreted cau-
tiously.20 6 This warning is curiously weak. If the data correctly in-
dicated that at day fifty-one an error rate greater than one-third
occurs, more than caution is needed. Clearly, at that point, the
tests are unreliable.
The way to prevent this unreliability would seem to be simply to
minimize storage by having the blood of the victim or defendant
typed as quickly as possible. This study, however, presents the
need for a more thorough consideration of the problem. The re-
searchers were able to accurately group all ten PGM samples
through day thirty-two, and consequently, no warning was issued
about blood stored for less than five weeks. However, were ten
testings enough to support a conclusion of reliability for up to five
weeks? The study only examined blood stored at room tempera-
ture. Do other storage conditions bring about quicker alterations?
Finally, why are false positives reported in the stored blood, but
not in the dried? Is there some reason that the bloodstain should
show less deterioration than the whole blood? If more testing of
stains were done, would erroneous readings also be found? While
204 In support of the statement that postmortem samples have shown alterations, Zajac
cites B. Campbell, L. Luke, & M. Cowan, EAP, EsD, and PGM in Post Mortem Blood
(1978) (unpublished paper, Cuyahoga County Coroner's Laboratory, Cleveland, Ohio). See
Zajac, supra note 17, at 168.
l0b Rees, Howard, & Strong, The Persistence of Blood-Group Factors in Stored Blood
Samples, 15 J. FoRENSIc SCI. Soc'Y 43 (1975) [hereinafter cited as Persistence of Blood-
Group Factors].
IN Id. at 48.
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these questions and others like them seem important for accurate
phenotyping, attempts to answer them do not appear in the
literature.
It is well established that PGM can be detected in body tissues
other than blood. The enzyme is found in semen, for example. One
study has found, however, that semen contaminated with saliva al-
ters the electrophoretic bands of PGM.0 7 Once that finding was
reported, it would seem logical to ask whether saliva or other con-
taminants20 8 could alter PGM readings in bloodstains. Neverthe-
less, even though stains might often contain contaminations from
other body fluids, no one has studied this potential area of
unreliability.
In summary, then, the PGM studies so far have reported no false
positives in bloodstains, 209 but the research has been limited. In
addition, other areas of PGM study have found erroneous readings
that could affect criminal investigations and that should raise
questions about the validity of PGM phenotyping in dried blood.
Even so, these avenues of research have not been followed, leaving
large gaps in knowledge about the detection of this genetic marker.
2. AK Reliability
The adenylate kinase research mirrors that done on PGM. Al-
though the study of AK in stains has not been far ranging, no false
positives in bloodstains have been reported. The Denault Study
consisted of only twelve samples dried at room temperature and
two frozen samples, all of which were AK "1.'210 AK, like PGM,
207 See Sensabaugh, Blake, & Northey, Genetic Markers in Semen III: Alteration of
the Phosphoglucomutase Isozyme Patterns in Semen Contaminated with Saliva, 25 J. Fo-
nENsic Sm. 470 (1980) [hereinafter cited as Genetic Markers in Semen III].
1 The authors stress that they only studied semen samples contaminated with saliva
and that alterations in the PGM readings may occur from other bodily fluid contaminants.
Id. at 477.
0 Zajac reported that "[t]he cathodal bands of some of the more rare phenotypes (the
PGM 8-1, for example) lose intensity and degrade sooner than other isoenzyme bands,
which may lead to the possible mistyping of the phenotype as a PGM 1." Zajac, supra note
17, at 168. Zajac cites nothing in support of this statement.
210 Denault Study, supra note 32, at 493. Similarly, all the blood examined by Rothwell
was AK "1." See Rothwell, supra note 136, at 231. The AK system is not as forensically
valuable a system as some others. It does not have a high discriminating power among a
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also has exhibited erroneous readings in stored bloody.2 1 Finally,
like PGM, the AK research shows little scientific inquiry into pos-
sible areas that might produce unreliable phenotyping in stains.
3. ADA Reliability
A little over a decade ago, a leading British forensic serologist
stated that, "The assay of ADA is not easy and at present different
methods so far published and tried appear to give markedly differ-
ent results. 212 In spite of that conclusion, the study of possible
false adenosine deaminase positives in dried or preserved blood is
even less than for the PGM or AK systems. The electrophoretic
procedure used by the Denault Study produced no erroneous ADA
readings on the fourteen tested samples. That research revealed,
however, that ADA was less stable than other enzymes,213 and per-
sisted best under conditions that do not favor the preservation of
other genetic markers.21 Meanwhile, Zajac reports, without cita-
tion to any source, that, "The ADA system has been shown to ex-
hibit alterations in band patterns in dried, stored and bacteria-in-
fected blood samples."21 Even though this statement would seem
to lead to the conclusion that the forensic ADA typing is unrelia-
ble, neither Zajac nor any other published author further explores
this contention.
population since more than 90% of the people have type AK "1' Id. See Baird, supra note
1, at 113-14.
2,1 See Persistence of Blood-Group Factors, supra note 205, at 47-48. The authors re-
port that at days 109 and 122 of the storage, two AK "2-1" samples were read as "1" and
they therefore concluded that AK results are not reliable for blood stored over twelve weeks.
Id. AK is generally regarded as a stable enzyme and more reliable than PGM. See also B.
CULLIFORD, supra note 3, at 138; DISTRmUTIoN or HuMAN BLOOD GRouPs, supra note 25, at
38; Rothwell & Sayce, The Stability of PGM and AK Isoenzymes in Human Tissues, 19 J.
FORENSlC Sci. 590 (1974); Zajac, supra note 17, at 168.
212 B. CULLIFORD, supra note 3, at 174.
213 See Denault Study, supra note 32, at 493-94.
214 The researchers found that the electrophoretic bands of ADA were more distinct for
the samples aged at the higher humidity, but the authors also concluded that "blood sam-
ples in general should be preserved at low temperature, where the humidity is also low." Id.
at 494.
215 Zajac, supra note 17, at 168.
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4. EsD Reliability
EsD "is not particularly stable. '216 All esterace D phenotypes do
not degrade at the same rate.21 7 As a consequence, "the EsD sys-
tem is subject to alterations in the phenotype patterns which could
lead to mistypings if the forensic serologist is not aware of such
possibility. 2 18
The first report of successful EsD typing in dried blood was pub-
lished in 1975, although this work also found that as the blood
aged it became very hard to distinguish EsD "1" from "2-1. "219 In
1979, a pair of researchers published what they termed "a compre-
hensive stability evaluation" of EsD.220 They reported that as the
bloodstain ages, -band 1 in EsD "1" loses intensity more quickly
than bands 2 or 3, and that in EsD "2-1," band 2 loses intensity
more rapidly than bands 1 and 3.221 The researchers summarized
their results as follows: "With these criteria, no error was encoun-
tered in grouping stains up to four weeks of age. Stains older than
four weeks could not be grouped. '222 They concluded that if the
serologist is aware of these changes during aging, no mistyping will
occur, although they implied that erroneous readings will be given
if these alterations are unknown to the person typing the stain. 2 3
"I Baird, supra note 1, at 116.
217 See Rothwell, supra note 136, at 233.
218 Zajac, supra note 17, at 168.
2' Parkin & Adams, The Typing of Esterase D in Human Bloodstains, 15 MED. ScI. &
L. 102, 103 (1975).
220 See Jay & Philp, A Stability Study of the Esterase D Isoenzymes, 24 J. FORENSIC
SCI. 193, 193 (1979). Even though labeled "comprehensive," the only drying condition stud-
ied was that of room temperature. Certainly blood can age under other conditions. A stain
on clothing, for example, may have dried at body temperature and have been subjected to
perspiration or washing. The study does not indicate whether the typing of the aged sam-
ples was done "blind," that is, with those doing the typing not knowing the phenotypes in
the samples. If not done blind, the study also can be faulted on this ground. A study is not
comprehensive just because those who produced it say it is. Once again, this study, the most
detailed on EsD, really points out how little research has actually been done.
221 Id. at 195.
222 Id. at 196.
22 It should follow that if the person doing the bloodstain analysis is not familiar with
these characteristic degradation effects, the subsequent phenotyping is not reliable. No re-
ported cases indicate whether the forensic personnel were aware of these conditions. This is
true even in People v. Bush, 103 Ill. App. 3d 5, 430 N.E.2d 514 (5th Dist. 1981), in which the
blood tests must have been performed only shortly after the article detailing the deteriora-
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5. Hp Reliability
A decade ago Culliford stated that haptoglobin stains had to be
less than three days old to be reliably typed and that Hp "2-1" can
appear as "1_1. ' '224 Apparently shortly thereafter a new procedure
and new equipment gave forensic scientists increased confidence in
their ability to type Hp in dried blood.225 In 1979, however, an-
other new procedure was developed. "Bloodstains ranging in age
from approximately six weeks to two years . . . were accurately
phenotyped in haptoglobin by electrophoresis after the samples
were prepared by a newly adapted chloroform procedure. '226
Stolorow and Wraxall, the developers, concluded that without this
new technique, haptoglobin was uninterpretable in stains after six
weeks.
The developers' conclusion is interesting when compared to the
analysis done in State v. Fulton.227 In this case, following a violent
robbery on February 7, 1979, the defendant was arrested on that
night and a bloodstain was seen on his shoe. The shoe, however,
was first sent to a forensic laboratory for analysis of the stain on
April 10, 1979, making the minimum age of the dried blood ap-
proximately nine weeks at the time of the forensic tests. According
to Stolorow and Wraxall, without their newly developed method,
Hp analysis should have produced uninterpretable results. Their
method, however was not published until after April 1979, making
it doubtful that it was applied in Fulton. Even so, a forensic serol-
tion characteristics was published. The study had a publication date of January, 1979, the
bloodstains and other blood samples in Bush were collected on May 30, 1979, and presuma-
bly analyzed shortly thereafter. One can only speculate whether the absence of any mention
of the Jay & Philp article also indicates a lack of knowledge of its contents. Bush also is
curious because, though other enzymes are more stable than EsD and problems with EsD
typing have been reported, the only phenotyping reported was of the ABO and EsD sys-
tems. Nothing in the opinion indicates why the analysis was so limited.
24 B. CuLLwoRD, supra note 3, at 216. Unlike the other genetic markers discussed here
which are typed through electrophoresis, Hp is not an enzyme, but a serum protein. See
Baird, supra note 1, at 118.
225 See Baird, supra note 1, at 118. Baxter likewise states that- "It is only with the
development of sophisticated equipment that haptoglobins can now be reliably typed in
bloodstains." Baxter, supra note 2, at 287.
2,6 Stolorow & Wraxall, An Efficient Method to Eliminate Streaking in the Electro-
phoretic Analysis of Haptoglobin in Bloodstains, 24 J. FORENSIC Sci. 856, 861 (1979).
227 229 N.C. 491, 263 S.E.2d 608 (1980).
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ogist stated at trial that the bloodstain contained Hp "2-1," which
was the same phenotype as the victim's.
Several things should be noted from this. Although nothing spe-
cific is mentioned in the opinion, perhaps there is a way to recon-
cile this apparent conflict between the researchers and the state's
forensic expert. The court's inattention to this conflict may have
resulted from the absence of a defense challenge to the admissibil-
ity of the tests. The prosecution's witness, no doubt, indicated that
her Hp analysis of the bloodstain was reliable, even though not all
forensic serologists would have agreed with her. Surely this ought
to give pause again to defense counsel who do not challenge such
assertions and to courts that accept these assertions without insist-
ing upon thorough reliability studies.
6. EAP Reliability
In State v. Washington,2 28 the court, presented with conflicting
evidence about the reliability of the tests for erythrocyte acid
phosphatase in bloodstains, upheld the admissibility of the proce-
dures.229 A closer look at the merits of that dispute is in order. 30
The court was impressed with the state's expert who testified that
the EAP "enzyme was less likely to deteriorate when dried than if
kept in liquid form. He testified that EAP enzyme analysis on dry
blood stains was reliable, and that this reliability was well estab-
lished. 21  This opinion was supported by the research done by the
228 229 Kan. 47, 622 P.2d 986 (1981).
229 See supra text accompanying notes 110-22 for an analysis of the contradictory ex-
pert testimony presented in Washington concerning the reliability of enzyme typing of
blood samples taken from the crime scene.
130 Errors can easily occur in reading EAP electrophoretagrams if done by insufficiently
skilled personnel: "The EAP system is sometimes difficult to interpret since the phenotypes
depend not only on a pattern of relative mobility of the isoenzyme bands but also on the
relative intensities of the bands." Zajac, supra note 17, at 167. Therefore, "the results are
somewhat more difficult to read than those of some of the other systems and the serologist
should have a considerable amount of experience in using this system before applying it to
routine casework." Baird, supra note 1, at 115.
21 State v. Washington, 229 Kan. 47, 51, 622 P.2d 986, 990 (1981). For the problems of
typing EAP in aged whole blood, see DiSmnUTN OF HUMAN BLOOD GROUPS, supra note 25,
at 41. The authors therein state that electrophoresis "in fresh blood samples, produces two
main bands and some fainter ones. In older blood specimens additional bands appear which
render typing difficult." Id.
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Denault Study, who, according to the court, "concluded that EAP
enzymes did not deteriorate for a period of up to thirteen
weeks. 232
The basis for the "well established" reliability opinion was not
given. Other forensic serologists have reached less dogmatic con-
clusions. Baird, for example,- states that, "One disadvantage is that
the [EAP] enzyme is not particularly stable in dried bloodstains
and hence they have to be not more than 2-3 weeks old for success-
ful typing. Older stains can give spurious results. '233
Even the study by the Denault Study does not support the blan-
ket conclusion that EAP bloodstains remain without deterioration
for thirteen weeks. Instead, those scientists gave a limited conclu-
sion to this phase of their work. They only placed their findings
within the framework of the other EAP literature after first noting
that "a large discrepancy exists in the detectability of the EAP
isoenzymes in stains. Reported time limits for their identification
vary from a few days to eight or nine weeks. This study has shown
that EAP isoenzymes can be detected after 13 weeks of storage
under a variety of conditions. ' 234 This research does not conclude
that no deterioration occurs; instead, it establishes that on twenty-
four stains (two of which were frozen), accurate phenotyping was
done at thirteen weeks with the specified aging conditions. Indeed,
this study actually indicates that deterioration happens by thirteen
weeks. The authors reported that "[alt 13 weeks, greater enzymatic
activity was consistently observed for the specimens aged under
the higher humidity level (66%) than for those stored at the low
level (20%)."25
Deterioration, however, does not necessarily mean unreliable
tests. The crucial concern is whether deterioration results in false
positives. While the Denault Study reported no erroneous read-
ings, Grunbaum testified at the Washington trial that EAP analy-
sis often gave erroneous readings. The court rejected Grunbaum's
:32 229 Kan. at 52, 622 P.2d at 990.
'3 Baird, supra note 1, at 115.
284 Denault Study, supra note 32, at 494.
35 Id.
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work, however, noting that "Dr. Grunbaum used a different
method than is used in the method developed by Wraxall."23 6 This
assertion is particularly interesting, since Grunbaum's published
work has shown that false EAP positives are obtained on both me-
diums-cellulose acetate membranes and starch gel.237
In Grunbaum's study, done in conjunction with Zajac, samples of
whole fresh blood with known EAP phenotypes, were applied to
clean cotton cloth and dried at room temperatures for nineteen to
twenty-six days. Portions of the liquid blood were also stored at
body temperature for up to two days and then frozen to prevent
further deterioration until the phenotyping was done.
The blood samples were prepared in this manner to simulate
the adverse conditions which may take place in actual
casework submitted to the crime laboratory. It is not uncom-
mon to have dead bodies and bloodstained clothing or objects
subjected to heat and humidity for several days prior to dis-
covery and collection. Air temperatures are frequently near or
above body temperature (370C) and can be considerably
higher in desert or tropical climates, in closed rooms, closed
automobiles, or in direct sunlight.238
In spite of what the Washington opinion indicated, the typing was
done with both cellulose acetate membranes and starch gel. The
starch gel procedure was "essentially that described by Wraxall
and Emes with minor modifications and improvements developed
at the University of California's White Mountain Research Sta-
tion. ' 2 3 9 The phenotyping was done in a completely blind manner
by competent people:
The results were read independently by four individuals hav-
ing extensive experience with both methods of EAP phe-
notyping, in research and casework situations. The readers
1* State v. Washington, 229 Kan. 47, 55, 622 P.2d 986, 993 (1981). The state's witness
indicated that the medium used by Wraxall was a starch gel base while that used by
Grunbaum was a cellulose acetate membrane.
2 1 See Zajac & Grunbaum, Problems of Reliability in the Phenotyping of Erythrocyte
Acid Phosphatase in Bloodstains, 23 J. FoPENSlC SCL 615, 617 (1978).
2" Id. at 616.
339 Id. at 616 n.3 (referring to Wraxall & Emes, Erythrocyte Acid Phosphatase in
Bloodstains, 16 J. FoRENSIC SCI. Soc'y 127 (1976)).
[Vol. 31904
WILL BLOOD TELL?
had no knowledge of the phenotypes, the age of the samples,
or the way in which they were prepared prior to analysis.""
The starch gel readers did a total of twenty-eight readings of stains
and heat degraded samples; ten were wrong.241 Three out of twelve
stains were incorrectly phenotyped, while false positives were reg-
istered for seven of twelve heat degraded samples.
A total of forty-six readings of stains and heat treated liquid
samples were done on cellulose acetate. Seven of those forty-six
were labelled inconclusive. Six more were called inconclusive, but
with tentative readings given. Three of those six tentative readings
were wrong. "Successful" phenotyping was therefore done on
twenty-seven samples; three of these were wrong.2 42 The total rate
of false positives in this study thus exceeded twenty-five per cent.
These false positives occurred not because the readings bordered
on the inconclusive but because of changes in the blood samples.
"The problem with misidentification of the samples in this study
was not due to weak or indistinct band patterns. Rather, discrete
bands were present and readable, but they had been altered to in-
dicate erroneous phenotypes.
243
The Denault Study reported no false EAP positives; Zajac and
Grunbaum did. These differences cannot be explained merely by
stating that each used a different medium, because Zajac and
Grunbaum used both mediums. 24 1 Although neither scientific team
commented on the results of the other, Zajac and Grunbaum gave
a possible reason for the discrepancy. The two authors first stated
that others besides themselves had reported mistypings in aged
EAP samples, but also noted that "Wraxall and Emes report no
mistyping on 387 bloodstains aged from two days to six weeks."245
Zajac and Grunbaum pointed to a distinction between that study
240 Zajac & Grunbaum, supra note 236, at 616.
' This statistical data comes from Zajac & Grunbaum, supra note 237, at 616, Table 1.
242 These three incorrect readings were all in heat degraded samples. Id. at 616.
43 Zajac & Grunbaum, supra note 237, at 617.
24 Zajac & Grunbaum thus concluded that- "The results... indicate that there can be
a definite problem with the EAP phenotyping no matter which electrophoretic supporting
medium is used." Id.
215 Id. at 615.
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and their own: "Apparently the bloodstains they used were pre-
pared under laboratory conditions and the history of drying and
preservation were well known.
246
Using a study designed to approximate closely actual casework
situations (something other researchers failed to do), Grunbaum
and Zajac thus reported false EAP positives. At the least, this
raises questions about the forensic EAP phenotyping. The Zajac
and Grunbaum research, of course, does more than merely raise
some questions. Their work indicates that subjecting liquid blood
to body temperature heat makes the subsequent EAP phenotyping
unreliable since, of the thirty-two readings of the heat treated sam-
ples, fourteen were wrong.24
This conclusion about the effect of heat is supported by a more
recent report from actual casework. "In a recent homicide case,
several items of evidence from the victim, three suspects, and the
crime scene were submitted for analysis. A 'liquid' blood sample,
collected from the ground upon which the victim was found, was
submitted as a standard for comparison. ' 248 This liquid blood was
exposed "to temperatures exceeding 32'C (90'F) for several
hours. '249 It was then kept at room temperature for several days.
The subsequent EAP phenotyping gave a false positive. The au-
thor concluded that the erroneous reading was caused by the heat
and stated that, "Generally, when a blood sample is exposed to
excessive conditions it may undergo an alteration of the EAP
isozyme patterns and appear to be some type other than that origi-
nally coded."2 50
The scientific evidence, therefore, demonstrates that heat of ap-
proximately body temperature, even for a short period, degrades
the blood in ways that often produce false positive EAP readings.
This conclusion is important not only because liquid blood col-
lected in casework may have been subjected to such conditions,
246 Id.
20 Seven were typed on starch gel and three on cellulose acetate. Id. at 616.
1,8 Yeshion, Thermal Degradation of Erythrocyte Acid Phosphatase Isozymes in a
Case Sample, 25 J. FORENSIC ScI. 695, 696 (1980).
249 Id.
250 Id. at 697.
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therefore making the subsequent EAP phenotyping unreliable, but
also because of the questions that it ought to trigger. For example,
if heat produces unreliable EAP readings, how does heat affect the
typing of other genetic markers in liquid blood? The scientific
literature is silent. How does heat affect EAP phenotyping in
bloodstains? The importance of the answer to this cannot be over-
estimated. Blood, on hot days or in a closed room or automobile or
under many other circumstances, will be exposed to warm temper-
atures as it dries or as it ages. Does that result in false positives,
and thus unreliable phenotyping? Doesn't blood on clothing worn
by a person dry or age at above room temperature? A high per-
centage of bloodstains submitted for forensic analysis must fall
into this category. Even so, the scientific literature is silent about a
stain that dried or aged on clothing worn by a person. Finally, how
do warm temperatures during the drying or aging of a bloodstain
affect the phenotyping of genetic markers other than EAP? Again,
the scientific literature is silent.
E. The Reliability of Forensic Genetic Marker Phenotyping
To state that gaps exist in the knowledge about the phenotyping
of genetic markers in forensic casework is to understate the situa-
tion. Even so, as evidenced by the testimony in the cases and by
the widespread use by forensic laboratories, many feel that the
tests are reliable. Part of this confidence comes, perhaps, from the
fact that few of the people who use the tests have ever listed the
possible ways that the typing might produce untrustworthy results
and then scientifically examined these possibilities.
Even those scientists who have identified problems with the ge-
netic marker typing indicate that it can be done reliably. Thus,
Zajac, at the conclusion of her survey of possible areas of unrelia-
bility, states that: "Alterations in degraded blood do not pose se-
vere problems in interpretation if they are recognized for what
they are. Unrecognized, they can lead to errors in identification."2 51
This apparent minimization of the unreliability problem is incom-
prehensible when it is realized that it was Zajac who earlier posited
251 Zajac, supra note 17, at 168.
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that no way exists to recognize the alterations:
Phenotypes in some contaminated, dried, or putrified blood
may be in an altered and degraded state which gives an un-
ambiguous but false reading. Since it is impossible to subject
a standard to the unknown conditions of the environment and
aging that has altered the sample under examination, there is
no true basis of comparison and no empirical way to detect
that the phenotype has altered. Consequently, the analyst
should be hesitant to accept even "unambiguous" readings for
certain comparatively unstable systems if the history of the
sample is unknown, or if it has been subjected to aging and
adverse conditions.2 52
Thus, even though it is not possible to tell when the phenotype has
altered, reliability is somehow aided by knowledge of the history of
the sample.251 Looking at a reported case makes one wonder why
this is true.
In State v. Hampton,2 " the prosecution's witness testified that
on the night of January 21, 1977, he was with the defendant and
the victim when the defendant beat the victim to death with a car
jack. The witness then stated that he and the defendant placed the
body in an automobile trunk, drove to a lake, and dumped the
body in the water. The body was recovered on February 27, 1977.
52 Id. at 163.
I" Zajac also states that-
The history of the sample affects the typing results and samples subjected to ex-
treme and adverse conditions may appear other than what they are. There are
many variables which must be accounted for and the forensic serologist should not
be reluctant to report an inconclusive result when working with samples which
have been subjected to unknown or adverse conditions.
Id. at 168-69. Zajac and Grunbaum similarly note that-
Erythrocyte acid phosphatase is a useful system for the crime laboratory for both
fresh and degraded blood and bloodstains, provided the inherent problems of phe-
notyping this particular enzyme system are recognized. Because of the great num-
ber of variables affecting this enzyme system in vitro, phenotyping should not be
attempted unless the complete history of origin and handling of the sample is
known.
Zajac & Grunbaum, supra note 237, at 617. See also Denault Study, supra note 32, at 496
("With some knowledge of the history of a bloodstain, the criminalist can now determine
the reasonableness of performing certain analyses.").
2- 294 N.C. 242, 239 S.E.2d 835 (1978).
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The State also offered expert testimony tending to show that
the deceased's blood type was AB, EAP, Group B, a rare
blood type which normally occurs in only two or three percent
of the population. The same type blood was found on the
bumper jack allegedly used in the killing and on a leather
jacket found near the scene where the killing supposedly took
place.25
If histories of the samples are invaluable to accurate phenotyp-
ing, then what are the histories of these samples? The serologist
was not present when the blood was shed. His knowledge of the
samples' aging conditions before they were collected256 can only be
learned if the prosecution's witness has been telling the truth. The
very nature of a trial, however, means that the defendant is chal-
lenging that witness' truthfulness. Since the serologist has no sci-
entific way of determining veracity, the blood analysis cannot be
done solely under the hypothesis that the witness is honest. If he is
not truthful, what are the histories of the samples? Clearly, they
are not determinable. This same sort of problem will be evident
with any blood sample when the defendant does not concede the
same history as the prosecution theory proclaims.257 A conclusion
that the blood sample's history must be known before the reliable
detection of genetic markers can be done really is a conclusion that
the forensic serologist seldom, if ever, can do reliable phenotyping.
Even if it can be assumed that the witness was telling the truth
and all the aging conditions can be learned, this does not assure
error free analysis. A scientist can only guarantee that the typing is
accurate if controlled experiments have been done that match, or
at least closely approximate the case's actual conditions. Knowl-
edge of the sample's history is useful only if science knows how
those historical conditions affect genetic marker detection. The
history of the blood sample in Hampton thus only begins the ques-
tioning. What is known about phenotyping in a six week old
255 Id. at 245, 239 S.E.2d at 838.
I'l "[BIlood found at the scene of a crime degrades before and after collection."
Grunbaum, supra note 37, at 103.
257 "Frequently, the analyst is unaware of the age and history of the blood or bloodstain
and has no way of obtaining this information." Zajac, supra note 17, at 160.
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corpse?25 8 Or a submerged corpse? Or a corpse submerged at the
temperature of that lake? Did any exhaust fumes get into the
trunk while the body was transported? If so, how do those gases
effect the subsequent phenotyping? Did the trunk become warm?
If so, what effect did that temperature have?
Perhaps the corpse seems an extreme example, but similar ques-
tions abound about the jacket and the jack. *If the jack has oil or
dirt on it, how did that affect the phenotyping? What effects were
caused by the temperature changes that the jack must have under-
gone? The jacket was of leather. How does that substrate affect the
phenotyping? If the jacket was dirty or contained sweat or bacte-
ria, how was the phenotyping affected? How did the weather con-
ditions affect the jacket as it lay at the crime scene?
Similar questions should be legion in almost any criminal inves-
tigation in which blood is typed. The data concerning any of these
matters is minimal or more often nonexistent; certainly it is nonex-
istent on the crucial cumulative effect of such conditions. 59 In fact,
almost the only data supporting reliability of genetic marker detec-
tion in forensic detection consists of blood deposited on clean cloth
and dried at room temperature in a laboratory. Only a very consid-
erate criminal would leave such evidence behind for the police
serologist.6 0
No research has been done which comes close to duplicating the
conditions that can actually be expected to be encountered in a
criminal case. The forensic analysis, therefore, can only be consid-
ered reliable if, from the few tested conditions, extrapolations can
218 Although the case does not say so, the phenotypes ascribed to the victim no doubt
came from analyses done on the corpse's blood, since there is seldom a medical reason to
phenotype the red cell enzymes.
159 Zajac has noted that:
Age alone is not critical to the reliability of phenotyping a blood sample. Rather,
it is essential to consider the cumulative effects of substrate, biological quality and
quantity, environmental effects such as heat, humidity and contamination, and
the preservation and transportation of the samples prior to submission to the
crime laboratory.
Zajac, supra note 17, at 167.
260 See Baird, supra note 1, at 115 ("Most perpetrators of crime are not always so con-
siderate as to leave behind adequate quantities of their blood to ensure that it can be relia-
bly grouped in the EAP or any other blood grouping system.").
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be made to actual case conditions. Such extrapolation is, of course,
not a matter of proven science, but truly a matter of faith-that is,
the scientists, even though it has not been proven, believe that be-
cause something was true under one circumstance, it will be true
under other circumstances. No reason exists for such faith here.
Even under the usual laboratory conditions, reports of false posi-
tives exist. Nevertheless, no research has answered even the simple
question of the rate at which these errors occur.26x Thus, the relia-
bility of genetic markers detection even under the controlled labo-
ratory conditions is questionable. Certainly, then, no reason exists
to believe that under other circumstances the procedures are trust-
worthy, and many good reasons exist to believe that they are unre-
liable. The little scientific research that has considered conditions
other than the usual laboratory ones repeatedly has reported inac-
curate phenotyping. For instance, in research previously discussed
which would be relevant to the Hampton262 case, there is evidence
to show false positives in postmortem samples, in blood subjected
to heat, in stains dried on leather, and in stains contaminated with
bacteria. The evidence certainly does not establish that the genetic
marker tests are reliable as applied in actual criminal investiga-
tions; indeed, many reasons for their unreliability have already
been suggested. Knowing the history of the sample does not
change these facts.
V. CONCLUSION
Forensic serology has attempted to perfect methods of detecting
genetic markers in blood samples discovered during criminal inves-
tigations. These tests are new and different from traditional blood
grouping tests. In spite of this newness, the techniques to individu-
alize blood have already been widely adopted by forensic laborato-
261 In contrast to the lack of research into error rates in the context of criminal investi-
gations, research into error rates in paternity bloodtesting has shown a 200% decrease in
five years. See Terasaki, supra note 2, at 555. Terasaki argues that HLA bloodtesting is "a
very powerful, effective new tool in cases of disputed paternity," id. at 548, but also can
report that, after extensive testing under conditions which should prevail in disputed pater-
nity blood tests, the error rate had dropped from 1.08% in 1971 to 0.35% in 1976 with even
increased accuracy in the future. Id.
262 294 N.C. 242, 239 S.E.2d 835 (1978). See supra text accompanying note 255 for the
factual situation in Hampton.
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ries. These procedures, however, differ in important ways from
other scientific tests since they are often ends in themselves and
not merely means to other scientific advances. Consequently, wide-
spread acceptance and use by the forensic community does not
guarantee that the genetic marker procedures are reliable.
The cases that have considered the admissibility of the genetic
tests uniformly have placed the burden to prove unreliability of
this new evidence upon the defendants. This is the wrong ap-
proach because even if the forensic procedures are unreliable, the
defendant will be unable to establish this fact. The burden of
proof, rather, should be on the prosecution who should have to
show that the procedures are reliable.
The reliability of the tests is not revealed by the uses to which
the results are put. Instead, reliability can only be established by
careful scientific experimentation. The scientific literature contains
few studies that bear on reliability. In fact, little is known about
the reliability of these tests as they are used in actual practice.
However, the brief existing literature does contain proven and po-
tential areas of unreliability in the tests' uses. At this stage of de-
velopment, therefore, the forensic tests for the detection of genetic
markers in blood have not been proven to be reliable and should
not be admitted into criminal trials.
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